WO2002049507A1 - Analyte measurement - Google Patents
Analyte measurement Download PDFInfo
- Publication number
- WO2002049507A1 WO2002049507A1 PCT/GB2001/005634 GB0105634W WO0249507A1 WO 2002049507 A1 WO2002049507 A1 WO 2002049507A1 GB 0105634 W GB0105634 W GB 0105634W WO 0249507 A1 WO0249507 A1 WO 0249507A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fluid
- channel
- analyte
- skin
- measuring
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
- A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
- A61B5/14514—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/150022—Source of blood for capillary blood or interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150213—Venting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150358—Strips for collecting blood, e.g. absorbent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150412—Pointed piercing elements, e.g. needles, lancets for piercing the skin
- A61B5/150419—Pointed piercing elements, e.g. needles, lancets for piercing the skin comprising means for capillary action
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150442—Blade-like piercing elements, e.g. blades, cutters, knives, for cutting the skin
- A61B5/15045—Blade-like piercing elements, e.g. blades, cutters, knives, for cutting the skin comprising means for capillary action
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150755—Blood sample preparation for further analysis, e.g. by separating blood components or by mixing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15142—Devices intended for single use, i.e. disposable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B2010/008—Interstitial fluid
Definitions
- This invention relates to apparatus for and methods of measuring certain properties of a fluid particularly although not exclusively, bodily fluids and the concentrations of certain analytes therein. At least some aspects of the invention relate particularly to the measurement of glucose levels in blood and other body fluids such as cutaneous (interstitial) and sub-cutaneous fluid.
- cutaneous interstitial
- sub-cutaneous fluid cutaneous (interstitial) and sub-cutaneous fluid.
- Test simplification allows the assay to be performed by relatively untrained personnel in a "non-laboratory" setting.
- cardiac marker tests configured in a lateral flow immunoassay format with labelled antibody allow for early assessment of potential myocardial infarct .
- the invention provides a device for measuring the concentration of an analyte in a fluid, comprising a support member, analyte sensing means provided thereon for measuring said concentration and a microchannel in fluid communication with said analyte sensing means for conveying said fluid to said sensing means.
- a microchannel is used to convey the sample fluid to the sensing means.
- microchannel refers to a channel, of any suitable cross-section, whose lateral dimension is between approximately 10-500 ⁇ m.
- microchannels are beneficial for a number of reasons in the context of an analyte sensing device.
- a small sample volume is beneficial since it means that it is easier to provide a sufficient volume for a valid test.
- the volume of fluid required to carry out an assay is correspondingly small, in addition the microchannel allows to handle flow rates between 10 and 500 nL/min with a high resolution of the measurement over time, due to the low channel volume.
- the analyte sensing means can be arranged in any suitable configuration depending on the type of sensing means used (electrochemical, optochemical etc.).
- the analyte sensing means comprises one or more reagents to react with said analyte and thereby give a measurable output.
- a reagent may be located anywhere, but preferably the reagent or at least one of the reagents is provided on a wall of the microchannel. This arrangement is beneficial since it means that no additional volume is required in order for the sample liquid to be brought fully into contact with the reagent - i.e. the contact area is optimised.
- the invention provides a device for measuring the concentration of an analyte in a fluid, comprising a support member and a microchannel provided on said support member for conveying said fluid across the support member, wherein one or more reagents for reacting with said analyte is coated on a wall of the microchannel.
- such a device further comprises means for sensing the analyte - for example an electrochemical or a photometric detector.
- the devices set out hereinabove may be used for measuring any suitable analyte in any suitable fluid.
- a suitable sample of bodily fluid may be applied to the device .
- the device is integrated with means for extracting the fluid.
- this comprises means for penetrating the skin - in the case where the sample fluid is blood or interstitial fluid.
- a skin penetration member such as hollow needle, solid lance or the like.
- the device can be used both to collect the sample fluid and to measure the concentration of the target analyte - or at least give an output from which the concentration can be measured.
- the present invention provides a device for measuring the concentration of an analyte in a fluid, comprising a support member, means provided on the support member for sensing said analyte, wherein said support member further comprises fluid extraction means arranged to direct fluid to said analyte sensing means via a conduit on the support member.
- a fluid extraction means preferably a skin penetration means, most preferably a needle, lance or the like, is provided on a support member of a device for measuring analyte concentration.
- the combination of skin penetration means, e.g. needle, and support member, e.g. test strip, to be made disposable and thus as hygienic as possible.
- the preferred embodiments require a user merely to puncture their skin with a needle or the like and then blood or interstitial fluid may be conducted automatically onto or into the test member.
- Devices for extracting interstitial fluid are shown in the afore-mentioned Integ patents and International patent application PCT/US01/09673
- the combined needle/test member would normally be used in conjunction with a separate, non-disposable, measuring device for measuring the analyte concentration e.g. by means of the output of an analyte-reagent reaction, where appropriate.
- the dimensions of the needle, lance or the like may be suited to the particular application.
- any mechanism for extracting interstitial fluid may be used with the present invention.
- the present invention will be described with reference to a shallow penetration needle, the invention is application to any technique for obtaining a body fluid.
- a standard hypodermic needle several centimetres in length may be employed.
- the penetration member is of such a length that it penetrates substantially the cutaneous layer of skin.
- the cutaneous layer has a high density of blood capillaries which helps to ensure that the levels of analytes in interstitial fluid reliably reflect those in the blood.
- interstitial fluid While not limited to analysing interstitial fluid (ISF) , the present invention is preferably used in obtaining and analysing ISF.
- a further benefit offered by interstitial fluid is that it is not as complex as whole blood and therefore does not, for example, suffer from Haematocrit fluctuations.
- ISF also has a low viscosity and is more suited to passage through microchannels than whole blood. The low sample volume requirement of a microchannel also enables the device reliably to use interstitial fluid.
- the actual length of the penetration means will depend on the angle at which it is intended to be inserted. Thus if shallow angle penetration is intended, the length may by of the order of several millimetres e.g. up to approximately 7 to 10 millimetres. Preferably however substantially perpendicular insertion is intended and the length is less than 2 mm, preferably less than 1.5 mm. In some preferred embodiments a length of approximately 1.4 mm is appropriate. However for certain applications a length as short as 0.5mm may be preferred. Of course a given test member may have just one skin penetration member, or alternatively a plurality may be provided.
- the penetration means may comprise a sufficiently short standard needle, possibly shortened if necessary. More preferably the penetration means comprises a microneedle.
- a microneedle is hereby defined as a needle with a length sufficient to penetrate the cutaneous layer of human skin without substantially penetrating the sub- cutaneous layer. Such a needle typically has length less than 2mm, preferably between 0.4 and 1.6mm.
- the outer diameter is preferably less than 0.5mm, most preferably between 0.1 and 0.3 mm.
- the penetration means need not be integrated with the support member, but preferably is.
- the comments above regarding this arrangement apply, with the additional benefit noted here that preferred embodiments of this arrangement can provide a compact disposable device which gives rise to substantially no pain, in use and obviates the need for a user to come into contact with or even see the bodily fluid concerned.
- the analyte is glucose
- Preferred embodiments of the invention use a reagent -based measurement.
- Many different reagent-based analyte measurements are available to those skilled in the art, allowing the principles of the invention to find wide application.
- an optochemical- i.e. either fluorescent or luminescent - or an electrochemical technique could be used.
- One preferred embodiment comprises analyte sensing means comprising a mediated amperometric enzyme electrode.
- a ferrocene-mediated electron transfer from a glucose-oxidase catalysed reaction is a suitable means for detecting the level of glucose in a body fluid.
- lactate oxidase or lactate dehydrogenase and cholesterol oxidase dehydrogenase may be used to measure lactate and cholesterol levels respectively.
- electron-transfer mediator is a non-limiting example and that other electron transfer mediators well known in the art could be used, for example, hexa-cyanoferrate (ferricyanide) , oxygen or components of the respiratory chain (i.e. cytochromes) .
- the embodiment will comprise an analyte sensing means which operates in conjunction with a test meter to give the measurement.
- the member may comprise the appropriate reagent or dye for performing a colorimetric test in association with light sensitive means in the test meter. It will be seen that such arrangements are consistent with the test device being disposable since the costly elements of the sensing mechanism, such as the light sensitive means, electronic circuity etc., can be placed in a non-disposable test meter.
- Just single analyte sensing means may be provided, but preferably more than one is provided.
- a plurality of conduits direct fluid to be measured to respective analyte sensing means.
- the sensing means may be different so as to measure or test for different analytes in the fluid. Preferably however they are the same or at least are for measuring the same analyte .
- the invention provides a device for measuring the concentration of an analyte in a fluid, comprising a support member and a plurality of analyte sensing means provided thereon for measuring said concentration, wherein said device further comprises a plurality of conduits such that each of said sensing means has a conduit associated therewith, said conduits serving in use to direct said fluid to respective sensing means.
- the device whether it comprises a single or a plurality of conduit/analyte sensors, may be used to continuously measure the concentration of the analyte over a period of time. Periodic measurements may be taken i.e. the fluid is "sampled" at various periods over time, for example every 30 minutes.
- Fluid may continuously flow through the device or may be temporarily stopped by, for example, hydrophobic gates.
- the sensors may be of the single measurement type, after which the device is discarded or fluid is diverted to another conduit to perform another measurement.
- the total time taken to complete a measurement cycle or the time taken between measurements could vary and would depend upon the degree of monitoring or the analyte of interest.
- the plurality of conduits would allow for switching from sensor to another after a particular period of time, by diverting fluid flow from one conduit to another. Switching enables measurements to be performed without interruption to the fluid extraction or without having to recalibrate the sensors, which are known to drift after a period of time due to factors such as electrode fouling etc.
- analyte monitoring may be made on a truly continuous basis, without the user having to recalibrate or interact with the system.
- An advantage of performing a single measurement either in the case of a device with a single or plurality of microchannels is that drifting of the signal over time is no longer an issue that has to be considered and consequently simpler reagent chemistries may be employed in the analyte sensors. For example in the case of an electrochemical detection system, results may be obtained in as little as five seconds or less. Furthermore, such devices would not require storage reservoirs for collection of the waste fluid, since the waste fluid would be stored in the microchannel conduits themselves .
- measurements may also be conducted whilst the fluid is stationary.
- flow controlling means such as a hydrophobic gate or gates being activated to temporarily stop the flow of fluid through the microchannel once it had passed the sensing means. Isolating or shutting off a volume of fluid from the rest of the fluid sample would enable an end-point determination of the total amount of analyte present in the particular portion of the sample to be made.
- the sensing means may be electrochemical or non-electrochemical in nature - e.g. of the fluorescent or chemi-luminescent colorimetric sort.
- the sensing means may comprises an enzyme-coated electrode in the case of electrochemical measurement, or in the case of fluorescent colorimetric sensing the sensing means would comprise a suitable reagent dye.
- the term 'sensing means' does not necessarily refer to a complete assembly for giving a final reading, but rather to a means on the support member which yields an output which may be read to give a measure of the analyte concentration, e.g. by a separate test meter.
- Such devices according to embodiments of the invention as set out above could be arranged to be used in a mode similar to conventional test strips i.e. where a single fluid sample is placed on the device and is measured.
- devices of the sort set out above may be arranged to measure the concentration of any suitable analyte.
- the analyte ' s concentration may simply be an indirect indication of the property of the sample fluid which it is desired to monitor.
- a detection reagent e.g. an enzyme substrate or an antigen
- the added detection reagent or the product of the enzyme- catalysed reaction comprises the analyte.
- Devices in accordance with the invention can therefore be arranged to measure such analytes - i.e. it will be seen that such devices may be used to measure the activity of enzymes in a body fluid sample, or test whether antibodies to a particular antigen are present in the body fluid.
- the device is arranged to measure an analyte concentration directly - i.e. it is the concentration itself which is being monitored.
- concentration itself which is being monitored.
- An example of such a measurement would be glucose in blood, the concentration of which is an important parameter for those suffering from diabetes.
- the measuring device is suitable for measuring the concentration of an analyte, e.g. glucose, in blood or interstitial fluid.
- the device is preferably suitable for attachment to the skin of the subject who is to be measured.
- the subject may be an animal but is preferably human .
- the result of this in the preferred application of the invention to blood glucose monitoring is that an improved insight into glycaemic control and the effects of food, medication and general trends on the glucose level is given.
- the device could therefore include an alarm or means to activate an alarm in order to alert or wake the patient or any third party in case of a particular analyte level, for example in the case of hypoglycaemia.
- the devices comprise a penetration member with a sufficiently length substantially to penetrate the cutaneous layer of skin, most preferably integrally formed with the support member. It is further preferred that such devices comprises at least one microchannel for conveying the interstitial fluid to one or more of the sensing means.
- the present invention provides a device for measuring the concentration of a given analyte in a bodily fluid comprising means for attaching the device to the skin of a subject and a plurality of sensing means for making a plurality of measurements of said concentration over a period of time.
- this aspect of the invention provides a device which can perform a plurality of measurements in si tu, that is without user intervention being required. This has clear benefits in removing some constraints on the number, frequency and regularity with which measurements can be performed.
- Each sensing element in the device is designed to be used for a certain predetermined time during which the signal will not significantly drift over time. In this sense " significantly " represents the amount of drift permitted such the measurement result would not be affected by an clinically unacceptable amount. After such a period fluid is then switched to a new sensor and the process repeated.
- the device is provided with flow control means for influencing the flow of fluid to the sensing means . Any suitable flow control method may be employed with corresponding means to affect such a control method.
- the flow control means comprises a hydrophobic gate situated within the conduit/microchannel .
- a hydrophobic gate as herein disclosed refers to a hydrophobic surface region within a hydrophilic channel such that the flow of fluid is interrupted. By changing the hydrophobic nature of the gate, i.e. by making the hydrophobic region more hydrophilic, fluid may then be allowed to flow along the channel .
- Hydrophobic gates may be used to control the flow of fluid within a single microchannel or may be used to switch or redirect flow from one microchannel to another .
- the hydrophobic nature of the gate may be maintained as it is and a increased pumping force (e.g. provided by a mechanical or electro-osmotic pump) may be applied in order for the fluid to breach the hydrophobic gate .
- a pumping force e.g. provided by a mechanical or electro-osmotic pump
- the device is arranged to direct fluid sequentially to each of the sensing means.
- the timing of the direction of the fluid to the sensing means could be pre-configured for example by software within the meter, such that the fluid is switched after a predetermined period of time.
- the device comprises, or is adapted to interface with, control means to control said direction of the fluid to the sensing means. Such control is preferably automatic.
- control means may be such as to allow a user to specify when a measurement is to be made. This is beneficial as it allows measurement on demand which is useful for example in the case of blood glucose monitoring, as it allows the user to determine the effect on blood glucose of eating a particular snack or to determine how much insulin it is necessary to inject prior to eating or the user may simply want to carry out a check for reassurance. This enables the device to make periodic measurements of fluid from the body of the subject using fresh fluid for each measurement, thereby facilitating the desired object of monitoring the concentration of the substance in question over a period of time. Where, as is preferred, each microchannel or other conduit is associated with a respective flow control means, each may be individually addressable by a suitable control means.
- the device comprises a common fluid collection region in fluid communication with the bodily fluid to be measured - e.g. via a needle - each sensing means preferably being in selective fluid communication with said common collection region.
- each sensing means preferably being in selective fluid communication with said common collection region.
- the present invention provides a device for making a plurality of measurements of the concentration of an analyte in a fluid comprising a common sample collection site in fluid communication with the fluid to be measured and a plurality of sensing means for measuring said concentration.
- any suitable conduit may be provided for conveying the fluid to be measured to the sensing means, but preferred arrangements comprise microchannels as defined herein.
- the provision of microchannels allows many test elements to be positioned in close proximity thereby enabling even devices comprising a large number of sensing means to be made relatively small. This is beneficial in applications where the size and weight of the device is an important consideration, such as when it is attached to the user's body. .
- a very low sample volume means that rather than conduct the usual reaction rate measurement as in known electrochemical devices e.g. for detecting blood analytes such as glucose, where electron transfer is measured as a function of time to determine the rate of transfer, an end-point test can be carried out in which the total amount of analyte in the sample volume is measured, thereby consuming substantially all of the analyte.
- the present invention provides a method of measuring the amount of an analyte in a sample of liquid comprising providing an electrochemical measuring device having a sensor electrode within a microchannel, introducing said sample liquid into said microchannel, and measuring an aggregate current passed by said electrode to give an indication of said amount of analyte in the sample .
- This aspect of the invention also extends to an electrochemical device for measuring the amount of an analyte in a sample of liquid comprising a sensor electrode disposed within a microchannel and means for measuring an aggregate current passed by said electrode in use to give an indication of said amount of analyte in the sample.
- the invention also extends to an equivalent arrangement using a non-electrochemical sensing means - e.g. a colorimetric one.
- any suitable transfer means for transferring the fluid from the user's body to the device may be employed.
- methods such as suction, ultra-sound or iontophoresis may be used.
- the transfer means comprises a needle.
- the needle is a microneedle as defined hereinabove.
- the needle is preferably shaped to aid skin penetration.
- the tip region of the needle is preferably substantially conical.
- the tip region has a reduced cross-section - preferably less than 0.2mm in width, most preferably less than 0.05mm in width.
- the needle is preferably arranged to minimise the risk of blockage upon insertion into skin.
- the aperture of the needle may be provided on a side surface of the needle, rather than at the tip as is conventional.
- the aperture of the needle is recessed, thereby avoiding contact with the skin upon penetration and thus potential blocking and/or damage
- the needle preferably has a bore such that the sample fluid is drawn up by capillary action.
- Suitable needle bore sizes range preferably from 21-30 most preferably 25. Any suitable inert and biocompatible material for the needle may be employed.
- inert materials include but are not limited to stainless steel, gold, platinum and metal- coated plastics Most preferably one or more microneedles is employed as defined hereinabove.
- the methods above may be supplemented by applying pressure to the user's skin around the site at which it is penetrated. Such pressure could be applied purely manually, but preferably the device comprises means - e.g. suitably configured resilient means - to apply the pressure.
- the device may have skin pressurising means as explained in more detail below and as shown in the figures. Examples of skin pressurising means are set out in copending application US09/877,514 filed June 8, 2001.
- the devices of the preferred embodiments comprise display means to display the concentration of the analyte being measured such as blood glucose.
- Such display means may be coupled directly to the measuring device, but preferably it is separate from the device and receives data therefrom by telemetry.
- This approach has the advantage that the measuring device can be very light and thus comfortable to wear.
- the measuring device may be worn under clothing but monitored on a display means kept, say, in a pocket or for example in the form of a watch worn on the arm of the user, without the user having to disturb their clothing in order to view it.
- the device comprises or is coupled to means for administering a substance to a user on the device on the basis of the measured concentration.
- a substance to a user on the device on the basis of the measured concentration.
- the insulin pump could be a separate device or alternatively could be integrated within the analyte sensing device per se .
- Controlling means present for example within the meter could control the amount of insulin administered by the insulin pump in response to the level of glucose measured by the device.
- preferred embodiments of this inventive feature can allow a diabetic, to maintain control of his/her glucose levels with a minimum of intervention i.e. only to replace consumable items such as a sensor/insulin patch.
- the present invention provides an apparatus for administering a substance to a user comprising a measuring device for measuring the concentration of an analyte in a bodily fluid from said user, said measuring device comprising a plurality of analyte sensing means and at least one conduit, preferably a microchannel, for conveying said bodily fluid to at least one of the sensing means; the apparatus further comprising means to administer said substance to said user on the basis of said measurement of concentration.
- the measuring device preferably comprises a means for attachment to the skin of a user, for example in the form of a self-adhesive patch. This can provide a secure but comfortable arrangement for use over prolonged periods of time, and can be relatively unobtrusive.
- the means for administering the substance may be entirely separate from the measuring device or integrated therewith.
- an integrated administering means comprises a reservoir on or in the measuring device for dispensing the substance.
- the substance, such as insulin is contained within a reservoir on an adhesive patch.
- the actual means for getting the substance from such a reservoir could comprises anything suitable such as a pressurised supply in conjunction with a flow control means such as a valve.
- a pump is used.
- a single pump may be used both to administer the substance, such as insulin, to a user's body and also to draw out blood or preferably interstitial fluid, to a sensing means for making an analyte concentration measurement e.g. of glucose.
- a suitable device may comprise an adhesive patch comprising a microneedle (as defined herein) coupled to or in fluid communication with an array of microchannels and a separate needle for injecting insulin.
- a single pump e.g. a silicon micro-pump, may be used to inject insulin from a reservoir on the patch and to draw interstitial fluid over a glucose sensing means to a waste reservoir.
- control and/or data processing means these will generally comprise electronic means such as an integrated circuit or the like.
- a power supply is then also required.
- control/processing means are portable . It or they may be provided in an integral package with the device e.g. the adhesive patch. Alternatively the control/processing means and/or power source may be provided separately and communicate with measuring device via a wire or wireless telemetry link as mentioned above.
- the power source may be a battery or may be a 'renewable' source such as a solar cell or a dynamo energised by movement of the user. Of course a combination of these could be employed.
- Measuring devices in accordance with the present invention may be fabricated using any suitable technique.
- the microchannels may be made using any suitable micro- fabrication technique such as but not limited to embossing, plasma etching or injection moulding
- electrodes are provided on opposing sides of a fluid channel by forming a first channel which is filled with a conductive material, and forming a second channel for conveying the test fluid, the second channel cutting across the first thereby thereby forming two conductive portions within respective opposite sides of the second channel .
- the conductive portions formed in accordance with the invention could be utilised for an electrochemical sensor arrangement .
- Micromachining techniques for making the abovementioned intersecting channels are preferred since they can be used to fabricate microchannels which can be formed close to one another, permitting dense arrays thereof.
- the driving electrodes are preferably positioned in close proximity to one another. This allows high electric fields to be achieved without applying unnecessarily high voltages.
- driving electrodes are provided substantially on one side of a channel . In one embodiment the driving electrodes extend around the wall of the channel.
- one or more electrodes may be formed on a second substrate which is then laminated to the main support member of the device.
- Methods used to deposit the electrodes onto the second substrate may be chosen preferably from a printing method, more preferably a screen-printing method.
- chemical or physical vapour deposition techniques could be employed.
- the electrodes according to all embodiments of the invention may be formed of any suitable inert material such as carbon, gold, platinum, etc.
- carbon electrodes optionally coated with reagents are provided on the second substrate by screen- printing, which is then laminated onto the support member thus closing the channel or channels and two gold electrodes are provided adjacent one another on a substrate laminated onto the support member for an electro-osmotic pump.
- a second substrate is provided, preferably it is arranged to close the channel provided on the support member. This allows a very straightforward fabrication method in which electrodes are formed within a closed channel.
- Lamination of one substrate to another will normally be carried out such that both laminates are perfectly aligned and that no further trimming or cutting is necessary.
- the device could be fabricated for example by firstly a lamination step followed by a cutting step whereby the second substrate may be trimmed to the shape of the support member.
- Lamination may be carried out by various methods such as ultrasonic or thermal welding or bonding, or by the use of an adhesive.
- the support member is formed with an integral needle at one end and the second substrate is then laminated onto the support forming a channel and leaving the penetration member exposed.
- the integrated skin penetration member is provided is open on one side.
- the penetration member is arranged so that upon insertion into skin, the skin itself effectively forms a wall of the member to that it can act like a hollow needle. Most preferably this is achieved by forming the penetration member with walls tapering away from the open side - e.g. a V shape .
- the invention provides an apparatus for obtaining and measuring fluid , comprising a skin penetration member having at least one longitudinal side open, the other sides being arranged so as effectively to cause the penetrated skin to act as the remaining longitudinal side of the member when the penetration member is inserted into the skin.
- the present invention provides a method of fabricating a device for measuring the concentration of an analyte in a fluid comprising providing a support member, forming an open channel on a surface of the support member and laminating a second layer onto said support member so as to close said channel.
- the invention also extends to a device fabricated using such a method.
- a light sensing means will, in general, be required.
- a light source may also be required, but is not always the case, for example in the case of chemiluminescent measurement.
- Any such light sensing means and/or the light source may be provided integrally with the non- disposable measuring device e.g. a test-meter. According to one embodiment it or they are provided separately of the part of the device which is brought into contact with the sample fluid - e.g. a skin patch. This means that the device itself can be made disposable while the relatively more expensive light sensing means and associated electronics for example could be provided in a separate test meter.
- the test device comprises means for optimising the light transfer from the sensing means to the optically sensitive means.
- such means comprises a lens, e.g. integrally moulded as part of the support member for the test device.
- the device may be arranged such that the light sensitive means views the sensing means along the conduit, e.g. microchannel, along which the sample fluid passes.
- the conduit preferably a microchannel, acts as a light pipe.
- the present invention provides an apparatus for measuring the light from an assay comprising an elongate conduit portion along which a sample fluid is drawn in use and a light sensitive means arranged to be sensitive to light coming substantially from the longitudinal axis of said conduit portion.
- a disposable skin patch is provided with a moulded plastics lens over the analyte sensing means.
- a corresponding test meter is designed to be placed over the patch and comprises a light sensitive element which sits over the lens when the meter is placed over the patch.
- Figure 1 shows a first embodiment of the invention, in the form of a skin patch, in cross section;
- Figure 2a shows an alternative microchannel arrangement
- Figure 2b shows a multiple channel/sensor arrangement
- Figure 3 depicts a cross section view of the skin patch of Figures 1, and 2 attached to the skin of the user with a controller unit attached to the skin patch;
- Figure 4 depicts a display unit
- Figure 5 depicts another embodiment of the invention, showing schematically a skin patch integrated with a needle, which also acts as an electrode, in cross section;
- Figure 6a depicts a microchannel and optochemical sensor in plan view
- Figure 6b depicts a microchannel and electrochemical sensor in plan view
- Figures 6c to e are cross sections of the microchannel of Figure 6b with fluid progressively entering the channel;
- Figure 8a shows a further embodiment of the invention, in the form of a single-use device with an integrated puncturing means
- Figure 8b is a cross section through a user's skin having the device of Figure 8a therein;
- Figures 8c and 8d depict the construction of a device similar to that in Figure 8a;
- Figure 8e is an alternative embodiment, shown in perspective view, of a puncturing means
- Figure 8f is a still further embodiment of an alternative puncturing means shown in perspective view
- Figure 8g is a side-sectional view of the embodiment of Figure 8f taken along line X - X in Fig. 8f;
- Figure 8h is a cross-sectional view of the lance of Fig. 8e in tissue
- Figure 8i shows an integrally formed base member and lance showing a vent and a capillary sensing channel, but with upper laminate removed for clarity;
- Figure 12a is a perspective view of a microchannel
- Figure 12b is a close-up, partial, perspective view of a microchannel; whereby electrodes are provided on opposing sides of a fluid channel by forming a first channel which is filled with a conductive material, and forming a second channel for conveying the test fluid, the second channel cutting across the first thereby thereby forming two conductive portions within respective opposite sides of the second channel .
- Figure 17a is top view, taken in perspective, of a first preferred embodiment of a chip for extracting and distributing a fluid sample and having a meander shaped waste reservoir;
- Figure 17b is the view of the embodiment of Figure 17a modified to illustrate a column shaped waste reservoir
- Figure 18 is a bottom view, taken in perspective, of the chip of Figure 17a;
- Figure 19 is a plan view of a measurement channel of the chip of Figure 17a;
- Figure 20a is a plan view of the meander shaped waste reservoir of the embodiment of Figure 17a;
- Figure 20b is a plan view of the column shaped waste reservoir of the embodiment of Figure 17b.
- Figure 21 is a plan view of the switching mechanism shown in Figure 20a.
- a skin patch 2 suitable for measuring the level of blood glucose in a user.
- Patch 2 is made up of two layers 3a and 3b
- the lowermost layer 3a is made of an suitable microfabricated plastic such as polyester, polycarbonate, polystyrene, polyimide, or other suitable microfabricatable polymers of suitable dimensions to allow it to be worn comfortably for a prolonged period of time, and optionally has an adhesive on its underside to allow the patch to be securely attached to the skin of a user.
- An optional pressure ring (5) is designed to apply pressure to the surface of the skin to enhance the flow of fluid from the body of the patient into the device.
- the pressure means may also be integrally formed and of the same material as that of 3a.
- FIG. 1 is shown for illustrative purposes only and as such the underside of 3a may be of any shape that would facilitate fixing of the device to the skin, for example when the pressure means is incorporated.
- the invention is not limited as such to a pressure ring and other types of pressure extraction designs could be used.
- a penetration device (4) e.g. a needle, lancet or cannula is attached to the lowermost layer 3a, through which fluid passes into the collection and fluid collection and distribution port (7) formed in the upper surface of layer 3a.
- Layer 3a has on its upper surface microfabricated channels. Port (7) is also formed by the same microfabrication process as the microchannels .
- a substrate layer 3b Laminated to the lowermost layer is a substrate layer 3b, preferably formed of the same material as that of the lowermost layer. This serves to close the microchannel.
- the microchannel and penetration member may optionally be coated with a hydrophilic material and/or an anti-coagulant such as a heparin attached to the inner surface such that during use it will not diffuse away.
- the microchannel system 8 corresponding electrochemical detectors 11 and optionally the electro-osmotic pump systems 10 and the hydrophobic gates 12
- Each of the electrochemical detectors 12 and electro-osmotic pump systems 10 are electrically connected via conductive tracks (not shown) to respective terminals (not shown) at the edge of the patch. Not shown in Figure 1 are the fluid reservoirs.
- Fig 2a shows another embodiment whereby hydrophobic gates are present on either side of the sensor.
- a controller unit 102 is brought into contact with these terminals so as to make electrical contact in use in order to transmit the measurement output signals between the patch and a display unit 103 (see Figures 3 and 4) .
- a control unit 102 for the patch 2 is shown in
- FIG. 3 As may be seen, this sits on top of the patch 2 and is secured to upper side of the patch in a suitable manner (not shown) .
- the control unit serves to control the fluid pumping mechanism, hydrophobic gates, fluid switching means and analyte sensors.
- the control unit is also provided with means such that radio frequency communication may be made, for example with the meter, for transmission and receipt of data.
- the control unit would also determine when all the microchannel/sensors had been used and transmit a signal accordingly.
- the control unit would also have means to detect any malfunctioning of the device and to also transmit this information.
- the control unit 102 is preferably battery operated and is capable of transmitting signals to a wireless display unit ( Figure 4) for example a radio frequency communicatio .
- Figure 2b shows a multichannel arrangement with the proximal end of the needle 4 is in fluid communication with a fluid collection and distribution port (7) formed in the substrate layer 3b of the patch. Radiating out from the manifold 6 are eighteen of the microchannel systems 8. Not shown is the fluid switching means.
- microchannel 608 is in direct communication with the port 607 into which the fluid flows from the needle 4.
- an electrode system comprising a pair of inert electrodes 610 providing electrosmotic flow.
- the electrodes are formed on a second substrate layer 3b (omitted from this figure for clarity) .
- the second substrate layer is then laminated onto the first substrate layer 3b thereby closing the microchannel 126 and bringing the electrodes 610 into contact with it.
- the electrodes 610 are positioned adjacent to each other, together forming an electro-osmotic pump system.
- an electric field is generated which drives fluid along the microchannel 608.
- one or more hydrophobic gates 612 Positioned along the microchannel 608 is one or more hydrophobic gates 612 which prevents the flow of fluid by capillary action along the microchannel.
- an electrochemical sensor 611 Downstream of the hydrophobic gate 128 is an electrochemical sensor 611 comprising at least two electrodes also formed on the upper substrate layer 3b. At least one further hydrophobic gate similar to the first, is optionally provided downstream of the sensor 12. This serves to stop the flow of fluid past the electrodes to allow the possibility for an end-point detection of the analyte.
- hydrophobic gates may be constructed of any suitable material, including, but not limited to, PTFE, polycarbonate, polyisobutelene, PMMA, dodecyl acetate, silicon rubber, synthetic way, octadocyl mercaptane, dodecyl mercaptane, and/or octa decyltrichloro silane.
- the skin patch 2 is attached to the skin of a user causing the needle 4 to penetrate substantially into the cutaneous layer of skin. Cutaneous fluid is drawn up the needle 4 and into the port 7 of the device.
- the controller unit 102 issues an appropriate signal to the electro-osmotic pump 610, in the form of a voltage difference across the two electrodes. This causes the fluid 136 to flow through the hydrophobic gate 128 and past the analyte sensor 611 until it reaches the second (optional) gate .
- a measurement is performed by the analyte sensors.
- the controller unit 102 is provided with control means or means to initiate the flow of interstitial fluid sequentially to each of the microchannels (8) after a predetermined period of time. Once all the tests on the patch 2 have been performed, the controller 102 transmits a signal to the display means 103 to alert the user so that the patch 2 can be discarded and a fresh one applied.
- microchannel 126 An alternative form of microchannel 126 is shown in Fig. 6a. This is similar to that shown in Fig. 6b except that the electrochemical sensor 611 is replaced by an optochemical one 615.
- the optical sensor comprises a reaction chamber 616 which for example contains Glucose oxidase (GOD) , Horseradish Peroxidase (POD) and a leuco-dye, (a colourless precursor of the dye molecule) . (e.g. 2 , 2-Azino-di- [3-ethylbenzthiazoline-sulfonate]
- the optical system is not limited to the above example and could comprise any suitable enzyme-dye combinations.
- the reaction which takes place is as below:
- Substrate / oxidized form of ABTS colour in accordance with the amount of glucose in the sample.
- the chamber 129 has an optically transparent upper surface. This arranged is to be aligned with the tip of an optical fibre in a modified control unit (not shown) so that the fibre is approximately 2 to 3 mm above the dye spot .
- the other end of the fibre is in optical contact with a light source and light sensitive diode sensor which is sensitive to a particular wavelength of light (for example 438nm in the case of ABTS) emitted by the transformed dye.
- the degree of absorption therefore gives a measure of the amount of transformed dye and thus the amount of glucose present .
- glucose present in the fluid acts as a substrate for GOD, which breaks the glucose down into glucono-1 , 5-lactone and hydrogen peroxide. POD subsequently catalyses the oxidation of the leuco-dye using the hydrogen peroxide, resulting in the production of a coloured dye which is subsequently detected.
- GOD gallate-di- [3-ethylbenzthiazoline-sulfonate]
- any suitable leuco-dye may be used, e.g.
- microchannels described as hereinbefore use electrochemical or colorimetric means to detect glucose.
- detection means such as infra red detection, filter photometry or Kromoscopy may be used.
- Figure 5 shows schematically a further preferred embodiment of the invention, similar construction to that of the previous embodiments and thus it has a hollow needle 106, for example but not limited to 1.4mm long and 0.3mm wide which penetrates substantially the cutaneous layer of the skin 113 of the user.
- the needle 106 also acts as an electrode which serves to extract fluid from the skin.
- At least one electrode 108 is provided such it makes contact with the skin.
- the needle is poised at a positive potential.
- an electric field is generated along the needle 106 and manifold 111 which stimulates the skin and increases the perfusion of interstitial fluid out of the skin.
- Figures 8a to 8d show two further embodiments of the invention.
- these are both single-use strips suitable for measuring blood glucose of a user. They are therefore used in a similar way to conventional test strips.
- a principle difference is that each has an integrated lance 119 at one end.
- the device 115 shown in Fig 8a is made essentially of a layer 116 onto which a second layer is attached or laminated (not shown) .
- the lowermost substrate layer 116 comprises a moulded or stamped microchannel 118, as well as the integrally formed lance 119 arranged in close proximity with the entrance 103 of the microchannel.
- the microchannel 118 maybe coated with suitable reagents, such as glucose oxidase in the case of glucose detection, which can be applied by any conventional means, such as printing for example screen- printing or ink-jet printing, or spray coating during manufacture.
- the microchannel may be free of enzyme, the reagents being provided on the electrode system (121) located on the underside of the uppermost layer (117) .
- the uppermost layer 117 may also be a conventional biosensor test-strip which could be attached to the lower surface such that the electrodes are positioned on the underside of the formed channel.
- This particular electrode system 121 comprises three electrodes 221 of which at least one is covered with layers of enzyme and electron mediator such as glucose oxidase and ferricyanide to form a working electrode for detecting glucose, as is well known in the art, the other two being a counter and reference electrode.
- the electrode system may comprise two working electrodes which serve to compare currents at each and measure the channel filling speed of the blood or interstitial fluid.
- the electrode system could comprise just two electrodes, a working and counter/reference.
- a venting device such that air may be displaced upon uptake of fluid into the microchannel.
- a vent or vents may be provided at any convenient location.
- Corresponding tracks 321 allow electrical connection to be made to the electrodes at the distal end of the strip when it has been inserted into a suitable test meter.
- the upper layer 117 may be slightly longer than the lower one 116 to allow access to the tracks 321 for this purpose .
- the lance 119 of the strip 115 in Fig 8a is essentially V shaped in cross section and tapers towards its tip. This means that when it is used to puncture a user's skin 123, as is shown in Figure 8b, the two sides of the V force back a portion of the skin 123, forcing the epidermis to form the remaining wall 123 of an enclosed channel 124.
- an open channel is effectively transformed into a closed one when it is inserted into skin.
- the microchannel 118 may also be formed with a V shaped profile for convenience of fabrication, but this is not essential as may be seen from the slightly modified embodiment of Figs 8c and 8d in which the microchannel 118' has a rectangular profile.
- the user pierces their skin with the lance 119 and interstitial fluid or blood is made to flow, by means of capillary action, through channel 124 formed by the lance (119) and the skin 122, into the microchannel 118 and thus over the electrochemical detector 121.
- the user then withdraws the strip 115 and inserts the opposite end into a conventional style test meter which makes electrical connection to the three conductive tracks 321.
- the meter is an integral part of the lancing system such that the user does not need to insert the strip into the meter and is automatically provided with the measurement result.
- Figures 8e through 8h show alternative embodiments of lances for penetrating into a body-fluid laden layer of skin as an alternative to the embodiment of the lance 119 of Figs. 8a and 8b.
- the lance 119a is an integrally formed pointed protrusion from the device
- the lance 119a is provided with an enlarged area 123a of the channel 121a.
- the enlarged area 123a also is cut completely through the thickness of the lance 119a.
- the capillary channel connects with the microchannel 118 of the device 115 of Fig. 8a. As shown best in Fig. 8h, the embodiment of Fig.
- a lance 119b is of a design similar to that of Fig. 8e is shown but excluding the large pooling area 123a. Elimination of the pooling area 123a permits a narrower transverse dimension to the lance 119b.
- the base member 116 and lances 119, 119a, 119b can be stamped from electrically conductive material .
- the base member may be an electrode.
- An electrically conductive base member and lance can be stamped from metal as described or formed in any other acceptable manner (e.g., photochemically etching a metal stock material, machining or other fabricating technique) .
- the electrically conductive base member can be made of stainless steel it can be also be plated with a second metal such as for example gold , platinum or silver.
- the electrically conductive base material may also be used as a counter electrode.
- Fig 8i shows an integrally formed base member and lance stamped from preferably one piece of sheet metal .
- the metal is preferably, but not limited to, stainless steel optionally coated with a noble metal such as gold or silver.
- a microchannel 84 onto which a second layer such as a test- strip could be attached. It is intended that such a device as illustrated in Fig 8i would be incorporated into a lancet firing device such that the device could be fired into the skin.
- the individual devices may be loaded and stored in a cassette comprising individually sealed pouches. Such a cassette could also be stored within the lancet firing device.
- the stamped penetration member with a rectangular vent 81 which also serves as a capillary break ensuring that once fluid is taken up by the lance 83 into the sensing zone 82, the flow of fluid is halted.
- the vent may be of any suitable size or shape.
- the ex vivo continuous monitoring system consists of several major subsystems including sample extraction, sample fluid distribution, and electrochemical detection. As will be more fully described below, a body fluid sample can be extracted from the skin and guided into a channel for the electrochemical determination of glucose concentration.
- each chip 400, 400a has for example, but not limited to, twelve measurement channels 402, 402a with switching mechanism
- chip 400a is identical to chip 400 except as will be described. Similarly elements are numbered similarly with the addition of an " a" to distinguish embodiments.
- the chip 400 has an edge connector 401 for electrically connecting electrodes (as will be described) to a controller (not shown) .
- a controller can contain logic, memory and processors for controlling the electronics of the chip 400 and optionally displaying any outputs (as, for example, the function and operation of controller 102 in Fig. 3) .
- the measurement results are transmitted by radio frequency by the controller to a remote control allowing the user to view the result and optionally to communicate or interact with the controller of the monitoring system.
- the sampling chip 400 extracts body fluid from the skin.
- the chip 400 extracts interstitial fluid (ISF) from substantially the cutaneous layer of a patient.
- ISF interstitial fluid
- the chip 400 includes a suitable cannula or needle 410, a spring- loaded hub 412 to pressurize the skin and means such as an adhesive 414 to fix the chip 400 to the skin.
- the needle 410 discharges the body fluid into a common distribution depression 416 shown best in Fig. 19).
- the distribution depression 416 is in fluid flow with the micro-channels 402.
- the shape and the volume to the distribution depression 416 is preferably a disk shaped void with 1 mm diameter and 100 ⁇ m depth. These dimensions and shape may vary depending upon the size, number and flow rate of individual channels.
- a portion of the micro-channel 402 between the distribution depression 416 and a ground or reference electrode 420 may be restricted in size to reduce flow rate variability and therefore control the rate of flow.
- Means may be provided within the device for the removal of undesirable gas-bubbles from the fluid sample.
- Such means could comprise a filter positioned between the needle and the common reservoir.
- the electrochemical detection system consists of an electrode system shown best in Fig. 19.
- the electrode system includes at least one working electrode 418 (by way of non-limiting example, gold or carbon) and a reference electrode 420 (e.g., silver/silver-chloride).
- the reference electrode 420 is circular to serve as a common electrode for each channel 402, thus reducing the number of contacts necessary.
- each channel can be provided with a unique reference electrode.
- Each channel 402 has a unique dedicated working electrode 418.
- a counter electrode (not shown) may be added.
- the electrodes 418, 420 are disposed to contact fluid in the channel 402.
- the channels 402 are formed as open channels in a substrate layer.
- the electrodes 420, 418 are screen-printed on an overlying laminate layer which also serves to seal the channels 402.
- the working electrode material is dependent on the enzyme ink being used. For example, one can distinguish between a redox- mediated system for the carbon working electrodes and an oxygen mediated system for the gold or platinum electrodes .
- an organo-metal- complex (which is linked to polymers forming the ink body) acts as a conductor and electron acceptor for the enzyme.
- the electrons are transported by the redox- mediator directly or by an electron hopping mechanism from redox-center to redox-center to the working electrode.
- the mediator is finally recycled to its original redox-state before it can react with the enzyme protein in a new cycle.
- glucose oxidase from aspergillus niger (GOD EC 1.1.3.4) and PQQ dependent glucose dehydrogenase (GDH EC 1.1.99.17).
- the enzyme ink is a cross-linked hydrophilic gel allowing the penetration of sample fluid but restricting the movement of the enzyme thus it is fixed to the electrode. This is an important property of the enzyme ink because the concentration of the enzyme has an effect upon the total response of the sensor. The same effect can be observed with the redox-mediator, due to the small molecular weight it cannot be entrapped in the same way as enzymes. Therefore, in the preferred embodiment, it is preferred to link the redox-mediator molecule to the large molecules such as the enzymes, proteins, or to the polymers of the ink material directly. In case of oxygen- mediated systems the situation is simpler.
- the enzyme ink needs only to contain enzyme as active component, the oxygen itself is dissolved in the sample fluid and is transferred to the sensor from the sample stream in the same instance as glucose.
- the oxygen- mediated system can be created with GOD based on the ability of the enzyme to build hydrogen peroxide from oxygen and glucose.
- Ox oxidized mediator species e.g. K 3 [Fe(CN) 6 ], p-benzoquinon, Ferrocinium
- Red reduced mediator species e.g. K 4 [Fe(CN) 6 ], hydroquinone,
- Hydrogen peroxide is a very reactive molecule, which can function as mediator to transport electrons for the enzyme to the electrode surface.
- the electrodes are deposited on a film such as polystyrene or polycarbonate of about 10 - 200 ⁇ m and, more preferably, about 30 to 75 ⁇ m) using screen-printing technology.
- a film such as polystyrene or polycarbonate of about 10 - 200 ⁇ m and, more preferably, about 30 to 75 ⁇ m
- the working electrode is coated with ink containing enzyme and in the case of carbon working electrodes with an ink containing enzyme and mediator.
- This coating step could be accomplished with the same printing methods as used for the electrode material.
- the production could be done in one machine with different print heads or stations on a continuous web. Such a process is described in
- FIG. 19 A schematic diagram of one measurement channel 402 is shown in Fig. 19.
- the channel 402 extents from the needle 410 and distribution depression 416 and through the main channel 402 (of dimensions for example of 200 ⁇ m x 100 ⁇ m) containing the electrodes 418, 420.
- a flow restricted portion of the channel 402 namely a small cross section (e.g., 30 ⁇ m x 30 ⁇ m) may be provided between the distribution depression 416 and the common electrode 420.
- a flow restriction levels out different flow rates during the extraction of the body fluid. These flow rate differences are caused due to the changing physiological conditions during the extraction. In general, one could observe a higher flow rate at the beginning of a sampling period compared to the extraction rate at the end. A thin capillary can counter-act this behavior.
- the electrodes 418, 420 are not part of the injection molded base plate of the chip 400. Instead, they are placed on top of the open U-shaped or rectangular channel 402 of the base plate of the chip 400 in a separate lamination step.
- the waste reservoir 406 stores the sample solution after its evaluation by the electrochemical sensing in channel 402.
- the size of the waste reservoir 406 defines the amount of time one channel can theoretically be used.
- the controller can activate the next channel to continue with the detection of glucose in the body fluid of a patient. It is important that the reservoir 406 is large enough to support more then a two-hour measurement .
- a chip 400 with twelve channels 402 can run for 24 to 28 hours allowing the patient a convenient change to a new chip (e.g. during his daily morning routines).
- reservoirs 406 larger then 5 ⁇ L (which is enough to support the flow for more then two hours with a flow rate of 30 nL/min) could allow longer runtimes.
- the entire chip 400 could last for more than one day.
- the number of channels in a device is not limited and may vary depending upon the measurement technique, the length of monitoring period and the size of the device and could exceed 100.
- Waste reservoir 406 is a meander-shaped extension of the channel 402. While easy to manufacture, such a design can build up high back pressure in the system, due to the weaker capillary force, then the design of waste reservoir 406a and is not as space efficient.
- the column filled reservoir 406a has advantages compared to the meander-shaped reservoir 406 regarding the size and the integration into a 12-channel chip 400a.
- waste channel 406a resembles a plurality of capillaries with a cross-section for example of 400 ⁇ m x 400 ⁇ m compared to only one capillary with the same cross-section in the design of waste reservoir 406.
- the shape of the columns is not limited to simple squares. They could be formed as circles, pentagons, hexagons, octagons or the like. Concerning the flow characteristics inside a column field the hexagon shaped columns shown are the most preferred version.
- the size and geometry of the channels and reservoirs may vary.
- the base plate of the chip 400 can be produced in a molding process, which is optimized for the small features and structures.
- plastics can be used for the base plate of the chip 400 (e.g. polystyrene, polycarbonate, polymethymethacrylate, polyester, and others) .
- Preferred polymers are polycarbonates. These allow a subsequent laser finishing to generate a secondary micro- or nano-structure (e.g., any desired patterns or other finishing can be formed in the micro-channel) .
- Polystyrene shows preferable characteristics in the lamination process. Thus polycarbonate could be used as the lower laminate and polystyrene used as the upper.
- the chip 400 itself consists of three major part a) the chip base plate with all the fluidic elements described above, b) the electrochemical detection system screen printed on a polymer foil, and c) the sampling hub with extraction needle. These elements are described in the foregoing sections.
- the most advantageous process is an adhesive-free thermal bonding process of the pre-printed foil to the chip base plate.
- the bonding happens at an elevated temperature with a stamping tool or a hot roller press.
- the temperature is close to the glass transition temperature (T g ) of the polymer thus the low molecular weight portion of the polymer will become mobile and tacky while the high molecular weight portion of the polymer still supports the integrity of the foil or film.
- the low molecular weight portion of the polymer will bond both pieces (base plate and foil with electrodes) together, additionally it will follow the shape of the printed electrodes, which can be between 5 and 30 ⁇ m thick. Therefore, one does not see a leakage between base plates and printed areas.
- Ideal bonding is achieved with the same thermoplastic polymers such as polystyrene on polystyrene or polycarbonate on polycarbonate. However, with the right regime and temperature/pressure combination polycarbonate can be bonded on polystyrene as well. But duro-plastic (non thermoplastic) materials are not suitable for such a process.
- the switching mechanism 404 allows the replacement of a used electrochemical system after a predetermined period of time.
- an electrochemical system is prone to fouling due to precipitation or adsorption of proteins or other species on the electrode surface.
- many different systems have been developed to overcome this problem.
- a classical example for such a system is the mercury-drop-electrode, where the mercury provides the electrode surface but every second the drop of mercury is replaced.
- the system never undergoes a continuous fouling process of a solid- state electrode.
- the renewal of the electrode surface is the most efficient but also the most dramatic strategy to avoid fouling.
- this same concept is used with all current disposable diagnostic glucose strips, where the test strip is disposed after a relatively short working time (5 to 15 seconds depending on the device) .
- a different strategy is the protection of the electrode by a semi permeable membrane, which allows the analyte to pass through to the electrode but not a large protein (or a red blood cell) .
- This concept is adopted in classical oxygen electrodes.
- the chip 400 uses a mixture of both concepts: a plurality of electrodes in different channels as well as an electrode protected by screen printable membrane (see German patent DE10052066.9 and related International patent application PCT/EP01/12073) . This allows the sensor electrodes to operate for several hours before the fouling shows a significant effect on the results and before the controller is switching to the next channel.
- FIG. 21 shows a schematic diagram of the switching mechanism 404.
- the switching system 404 includes electrodes 422 separate from the electrochemical detector electrodes 418, 420.
- the switching electrodes 404 allow local heating of a very small area on the thin foil such as polystyrene 424 overlying a well 426.
- the well 426 is in fluid flow communication with the end of the reservoir 406 except that the fluid flow is normally blocked by the foil 424. Due to this blockage, air cannot escape from the channel 402 and fluid from the distribution depression 416 cannot flow into the channel 402. Upon heating of the foil, this blockage is removed thus allowing the fluid to enter the channel.
- the temperature at the center point of the overlying electrodes 422 i.e., overlying the foil 424 above the well 426) very quickly rises over the glass transition temperature (T g ) of the foil in response to an application of a small current in the range of some 1/1000 Ampere with the effect that the foil 424 forms an opening above the hydrophobic well 426 allowing air in the channel 402 and reservoir 406 to vent into the well 426. In this event, the gas pressure in the channel 402 is relieved and fluid can flow from the distribution depression 416 and into the channel 402.
- the hydrophobicity of the well 426 prevents the sample fluid from flowing into the well 426 and leaking out of an opening formed in the film by reason of the energized electrodes 404.
- the controller opens a subsequent channel 402 by energizing its switching electrodes 422 to permit air to escape from the channel 402 and for the subsequent channel 402 to fill with body fluid. It should be appreciated that other methods for switching between channels and controlling fluid flow could be used and the invention is not limited by the above method
- the controller determine if the waste reservoir 406 is filled, is still filling at a constant rate, or if the needle 410 has dislodged from the cutaneous layer of the patient and the continuous sample stream has stopped.
- the waste reservoir 406 can be equipped with two electrodes (not shown) at the top and the bottom of the reservoir. Not in electrical contact with the sample fluid, these electrodes could measure the change in capacitance while the air inside the structure is slowly exchanged with sample fluid. The rate of the capacitance change will be directly proportional to the flow rate of the sample fluid and allow a close monitoring of the ongoing extraction.
- devices in accordance with the invention may measure the concentration of analytes other than those in bodily fluids .
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/432,827 US20040096959A1 (en) | 2000-12-19 | 2001-12-19 | Analyte measurement |
ES01271174T ES2421722T3 (en) | 2000-12-19 | 2001-12-19 | Analyte measurement |
JP2002550853A JP3935842B2 (en) | 2000-12-19 | 2001-12-19 | Analyte measurement |
EP01271174.3A EP1359837B1 (en) | 2000-12-19 | 2001-12-19 | Analyte measurement |
CA2432452A CA2432452C (en) | 2000-12-19 | 2001-12-19 | Analyte measurement |
AU2002222275A AU2002222275A1 (en) | 2000-12-19 | 2001-12-19 | Analyte measurement |
IL15639701A IL156397A0 (en) | 2000-12-19 | 2001-12-19 | Analyte measurement |
HK04109280A HK1066156A1 (en) | 2000-12-19 | 2004-11-24 | Analyte measurement |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0030929.4 | 2000-12-19 | ||
GBGB0030929.4A GB0030929D0 (en) | 2000-12-19 | 2000-12-19 | Analyte measurement |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002049507A1 true WO2002049507A1 (en) | 2002-06-27 |
Family
ID=9905366
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2001/005644 WO2002050534A1 (en) | 2000-12-19 | 2001-12-19 | Device for measuring blood coagulation and method thereof |
PCT/GB2001/005634 WO2002049507A1 (en) | 2000-12-19 | 2001-12-19 | Analyte measurement |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2001/005644 WO2002050534A1 (en) | 2000-12-19 | 2001-12-19 | Device for measuring blood coagulation and method thereof |
Country Status (13)
Country | Link |
---|---|
US (2) | US20040096959A1 (en) |
EP (4) | EP1359837B1 (en) |
JP (2) | JP3923429B2 (en) |
CN (2) | CN100458441C (en) |
AT (1) | ATE457064T1 (en) |
AU (2) | AU2002222275A1 (en) |
CA (2) | CA2432535A1 (en) |
DE (1) | DE60141252D1 (en) |
ES (4) | ES2421722T3 (en) |
GB (1) | GB0030929D0 (en) |
HK (2) | HK1065591A1 (en) |
IL (3) | IL156397A0 (en) |
WO (2) | WO2002050534A1 (en) |
Cited By (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1391716A2 (en) * | 2002-08-23 | 2004-02-25 | Lifescan, Inc. | Electrochemical test strip with an integrated micro-needle and associated methods |
WO2004041088A1 (en) * | 2002-10-30 | 2004-05-21 | Lifescan, Inc. | Method of lancing skin for the extraction of blood |
EP1346686A3 (en) * | 2002-03-05 | 2004-06-16 | Bayer Healthcare, LLC | Fluid collection apparatus having an integrated lancet and reaction area |
EP1464284A1 (en) * | 2003-03-28 | 2004-10-06 | Lifescan, Inc. | Integrated lance and strip for analyte measurement |
EP1479344A1 (en) * | 2003-05-22 | 2004-11-24 | Roche Diagnostics GmbH | Direct monitoring of interstitial fluid composition |
WO2004112602A1 (en) | 2003-06-13 | 2004-12-29 | Pelikan Technologies, Inc. | Method and apparatus for a point of care device |
EP1491143A1 (en) * | 2003-06-27 | 2004-12-29 | SensLab - Gesellschaft zur Entwicklung und Herstellung bioelektrochemischer Sensoren mbH | Diagnostic or analytic device for single use with integrated lancet |
JP2005077412A (en) * | 2003-08-28 | 2005-03-24 | Lifescan Inc | Analysis device and method equipped with estimation module |
EP1518509A1 (en) | 2003-09-19 | 2005-03-30 | Diabetes Diagnostics, Inc. | Medical device package, kit and associated methods |
WO2005034752A1 (en) | 2003-10-06 | 2005-04-21 | Lifescan Scotland Ltd | A lancing device using a piezoelectric actuator |
EP1566146A1 (en) | 2004-02-19 | 2005-08-24 | Lifescan, Inc. | Devices and methods for extracting bodily fluids |
EP1580552A1 (en) * | 2004-03-26 | 2005-09-28 | Lifescan, Inc. | Microfluidic analytical system with position electrodes |
EP1582169A2 (en) | 2004-03-31 | 2005-10-05 | Inverness Medical Limited | Medical device package with deformable retaining projections |
JP2005329364A (en) * | 2004-05-21 | 2005-12-02 | Dkk Toa Corp | Gas-liquid reaction unit and analyzer |
JP2005329365A (en) * | 2004-05-21 | 2005-12-02 | Dkk Toa Corp | Gas-liquid reaction unit and analyzer |
EP1611836A2 (en) | 2004-06-30 | 2006-01-04 | Lifescan Scotland Ltd | Fluid handling methods |
EP1611842A1 (en) | 2004-06-29 | 2006-01-04 | Lifescan, Inc. | Apparatus for the manufacture of medical devices |
EP1612143A1 (en) | 2004-06-29 | 2006-01-04 | Lifescan Scotland Ltd | Apparatus for the packaging of medical devices including integrated lancets |
EP1612142A1 (en) | 2004-06-29 | 2006-01-04 | Lifescan Scotland Ltd | Method for the packaging of medical devices, in particular integrated biosensors |
EP1612430A2 (en) | 2004-06-30 | 2006-01-04 | Lifescan Scotland Ltd | Methods for modulation of flow in a microfluidic pathway |
EP1611848A1 (en) | 2004-06-30 | 2006-01-04 | Lifescan Scotland Ltd | Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein |
EP1612429A2 (en) | 2004-06-30 | 2006-01-04 | Lifescan Scotland Ltd | Microfluidic flow modulation device |
EP1611839A1 (en) | 2004-06-30 | 2006-01-04 | Lifescan Scotland Ltd | Methods of monitoring the concentration of an analyte |
EP1611849A1 (en) | 2004-06-29 | 2006-01-04 | Lifescan, Inc. | Method of manufacturing integrated biosensors |
US20060204399A1 (en) * | 2002-12-30 | 2006-09-14 | Freeman Dominique M | Method and apparatus using optical techniques to measure analyte levels |
JP2007504434A (en) * | 2003-08-28 | 2007-03-01 | エポカル インコーポレイティド | Lateral flow diagnostic device using instrument-controlled fluidics |
JP2007503958A (en) * | 2003-09-03 | 2007-03-01 | ライフパッチ インターナショナル,インコーポレイテッド | Personal diagnostic equipment and related methods |
WO2007041062A2 (en) | 2005-09-30 | 2007-04-12 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
US7223248B2 (en) | 2003-08-13 | 2007-05-29 | Lifescan, Inc. | Packaged medical device with a deployable dermal tissue penetration member |
US7258673B2 (en) | 2003-06-06 | 2007-08-21 | Lifescan, Inc | Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein |
US7288073B2 (en) | 2001-07-20 | 2007-10-30 | Roche Diagnostics Operations, Inc. | System for withdrawing small amounts of body fluid |
US7343188B2 (en) | 2002-05-09 | 2008-03-11 | Lifescan, Inc. | Devices and methods for accessing and analyzing physiological fluid |
US7402616B2 (en) | 2004-09-30 | 2008-07-22 | Lifescan, Inc. | Fusible conductive ink for use in manufacturing microfluidic analytical systems |
EP1980206A1 (en) | 2002-05-09 | 2008-10-15 | Lifescan, Inc. | Minimal procedure analyte test system |
WO2008124597A1 (en) | 2007-04-04 | 2008-10-16 | Isense Corporation | Analyte sensing device having one or more sensing electrodes |
US7473264B2 (en) | 2003-03-28 | 2009-01-06 | Lifescan, Inc. | Integrated lance and strip for analyte measurement |
AU2004270984B2 (en) * | 2003-09-11 | 2009-05-14 | Ben-Gurion University Of The Negev Research And Development Authority | Sampling instrument |
US7618522B2 (en) | 2003-10-31 | 2009-11-17 | Lifescan Scotland Limited | Method of reducing interferences in an electrochemical sensor using two different applied potentials |
US7655119B2 (en) | 2003-10-31 | 2010-02-02 | Lifescan Scotland Limited | Meter for use in an improved method of reducing interferences in an electrochemical sensor using two different applied potentials |
US7665303B2 (en) | 2004-03-31 | 2010-02-23 | Lifescan Scotland, Ltd. | Method of segregating a bolus of fluid using a pneumatic actuator in a fluid handling circuit |
US7727467B2 (en) | 2003-06-20 | 2010-06-01 | Roche Diagnostics Operations, Inc. | Reagent stripe for test strip |
US7819822B2 (en) | 2004-03-06 | 2010-10-26 | Roche Diagnostics Operations, Inc. | Body fluid sampling device |
US7842235B2 (en) | 2004-02-14 | 2010-11-30 | Roche Diagnostics Operations, Inc. | Test element, system, and method of controlling the wetting of same |
US8000762B2 (en) | 2004-03-06 | 2011-08-16 | Roche Diagnostics Operations, Inc. | Body fluid sampling device |
US8012104B2 (en) | 2005-09-30 | 2011-09-06 | Intuity Medical, Inc. | Catalysts for body fluid sample extraction |
US8071030B2 (en) | 2003-06-20 | 2011-12-06 | Roche Diagnostics Operations, Inc. | Test strip with flared sample receiving chamber |
US8192787B2 (en) | 2004-08-16 | 2012-06-05 | Innoture Limited | Method of producing a microneedle or microimplant |
US8277636B2 (en) | 2003-09-02 | 2012-10-02 | Koji Sode | Glucose sensor and glucose level measuring apparatus |
US8287703B2 (en) | 1999-10-04 | 2012-10-16 | Roche Diagnostics Operations, Inc. | Biosensor and method of making |
US8293096B2 (en) | 2006-10-05 | 2012-10-23 | Lifescan Scotland Limited | Systems and methods for determining a substantially hematocrit independent analyte concentration |
US8298828B2 (en) | 2003-06-20 | 2012-10-30 | Roche Diagnostics Operations, Inc. | System and method for determining the concentration of an analyte in a sample fluid |
US8306592B2 (en) | 2003-12-19 | 2012-11-06 | Olympus Corporation | Capsule medical device |
US8333752B2 (en) | 2003-11-06 | 2012-12-18 | Lifescan, Inc. | Drug delivery with event notification |
US8388821B2 (en) | 2006-10-05 | 2013-03-05 | Lifescan Scotland Limited | Method for determining hematocrit corrected analyte concentrations |
US8460537B2 (en) | 2006-10-05 | 2013-06-11 | Lifescan Scotland Limited | Methods for determining an analyte concentration using signal processing algorithms |
US8507289B1 (en) | 2003-06-20 | 2013-08-13 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US8663442B2 (en) | 2003-06-20 | 2014-03-04 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
US8690796B2 (en) | 2002-04-19 | 2014-04-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8845549B2 (en) | 2002-04-19 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Method for penetrating tissue |
US8845550B2 (en) | 2001-06-12 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8905945B2 (en) | 2002-04-19 | 2014-12-09 | Dominique M. Freeman | Method and apparatus for penetrating tissue |
US8919605B2 (en) | 2009-11-30 | 2014-12-30 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
US8945910B2 (en) | 2003-09-29 | 2015-02-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8969097B2 (en) | 2005-06-13 | 2015-03-03 | Intuity Medical, Inc. | Analyte detection devices and methods with hematocrit-volume correction and feedback control |
US9046480B2 (en) | 2006-10-05 | 2015-06-02 | Lifescan Scotland Limited | Method for determining hematocrit corrected analyte concentrations |
US9089294B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9089678B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9095292B2 (en) | 2003-03-24 | 2015-08-04 | Intuity Medical, Inc. | Analyte concentration detection devices and methods |
US9144401B2 (en) | 2003-06-11 | 2015-09-29 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9261476B2 (en) | 2004-05-20 | 2016-02-16 | Sanofi Sa | Printable hydrogel for biosensors |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US9410915B2 (en) | 2004-06-18 | 2016-08-09 | Roche Operations Ltd. | System and method for quality assurance of a biosensor test strip |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9561000B2 (en) | 2003-12-31 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US9560993B2 (en) | 2001-11-21 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US9603562B2 (en) | 2002-02-08 | 2017-03-28 | Intuity Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
US9636051B2 (en) | 2008-06-06 | 2017-05-02 | Intuity Medical, Inc. | Detection meter and mode of operation |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9782114B2 (en) | 2011-08-03 | 2017-10-10 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9833183B2 (en) | 2008-05-30 | 2017-12-05 | Intuity Medical, Inc. | Body fluid sampling device—sampling site interface |
US9839386B2 (en) | 2002-04-19 | 2017-12-12 | Sanofi-Aventis Deustschland Gmbh | Body fluid sampling device with capacitive sensor |
US10330667B2 (en) | 2010-06-25 | 2019-06-25 | Intuity Medical, Inc. | Analyte monitoring methods and systems |
US10383556B2 (en) | 2008-06-06 | 2019-08-20 | Intuity Medical, Inc. | Medical diagnostic devices and methods |
US10531827B2 (en) | 2002-12-13 | 2020-01-14 | 2Breathe Technologies Ltd. | Apparatus and method for beneficial modification of biorhythmic activity |
US10729386B2 (en) | 2013-06-21 | 2020-08-04 | Intuity Medical, Inc. | Analyte monitoring system with audible feedback |
US20200330016A1 (en) * | 2017-12-15 | 2020-10-22 | Koninklijke Philips N.V. | Wearable or insertable devices with microneedles that include mechanically-responsive material |
Families Citing this family (339)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
US7310543B2 (en) * | 2001-03-26 | 2007-12-18 | Kumetrix, Inc. | Silicon microprobe with integrated biosensor |
EP1397068A2 (en) | 2001-04-02 | 2004-03-17 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
CA2448902C (en) | 2001-06-12 | 2010-09-07 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US7749174B2 (en) | 2001-06-12 | 2010-07-06 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge |
US7033371B2 (en) | 2001-06-12 | 2006-04-25 | Pelikan Technologies, Inc. | Electric lancet actuator |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
DE60234597D1 (en) | 2001-06-12 | 2010-01-14 | Pelikan Technologies Inc | DEVICE AND METHOD FOR REMOVING BLOOD SAMPLES |
US7699791B2 (en) | 2001-06-12 | 2010-04-20 | Pelikan Technologies, Inc. | Method and apparatus for improving success rate of blood yield from a fingerstick |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
WO2003025559A1 (en) * | 2001-09-11 | 2003-03-27 | Arkray, Inc. | Measuring instrument, installation body, and density measurer |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US20030212344A1 (en) * | 2002-05-09 | 2003-11-13 | Vadim Yuzhakov | Physiological sample collection devices and methods of using the same |
US7736309B2 (en) | 2002-09-27 | 2010-06-15 | Medtronic Minimed, Inc. | Implantable sensor method and system |
US7993108B2 (en) | 2002-10-09 | 2011-08-09 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
DE60336834D1 (en) | 2002-10-09 | 2011-06-01 | Abbott Diabetes Care Inc | FUEL FEEDING DEVICE, SYSTEM AND METHOD |
US7727181B2 (en) | 2002-10-09 | 2010-06-01 | Abbott Diabetes Care Inc. | Fluid delivery device with autocalibration |
US20050049522A1 (en) * | 2002-10-30 | 2005-03-03 | Allen John J | Method of lancing skin for the extraction of blood |
US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US7291310B2 (en) * | 2002-12-17 | 2007-11-06 | The Regents Of The University Of Michigan | Microsystem for determining clotting time of blood and low-cost, single-use device for use therein |
CN102620959B (en) * | 2002-12-26 | 2015-12-16 | 梅索磅秤技术有限公司 | Assay cartridges and using method thereof |
US7815579B2 (en) * | 2005-03-02 | 2010-10-19 | Roche Diagnostics Operations, Inc. | Dynamic integrated lancing test strip with sterility cover |
AU2003303597A1 (en) | 2002-12-31 | 2004-07-29 | Therasense, Inc. | Continuous glucose monitoring system and methods of use |
US20040193072A1 (en) * | 2003-03-28 | 2004-09-30 | Allen John J. | Method of analyte measurement using integrated lance and strip |
AU2004231988B2 (en) * | 2003-04-16 | 2010-04-15 | Drexel University | Acoustic blood analyzer for assessing blood properties |
US7679407B2 (en) | 2003-04-28 | 2010-03-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing peak detection circuitry for data communication systems |
WO2004107964A2 (en) | 2003-06-06 | 2004-12-16 | Pelikan Technologies, Inc. | Blood harvesting device with electronic control |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
NZ580449A (en) * | 2003-09-11 | 2011-06-30 | Theranos Inc | Ingestible medical device with biocompatible polymer coating, device with microarray to interact with disease marker |
US7299082B2 (en) * | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
USD914881S1 (en) | 2003-11-05 | 2021-03-30 | Abbott Diabetes Care Inc. | Analyte sensor electronic mount |
US7474638B2 (en) | 2003-12-15 | 2009-01-06 | Agilent Technologies, Inc. | Method and system for distributed baseband measurements |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
EP1718198A4 (en) | 2004-02-17 | 2008-06-04 | Therasense Inc | Method and system for providing data communication in continuous glucose monitoring and management system |
US7439069B2 (en) * | 2004-02-27 | 2008-10-21 | Nippoldt Douglas D | Blood coagulation test cartridge, system, and method |
US20050266571A1 (en) * | 2004-03-26 | 2005-12-01 | Phil Stout | Method for feedback control of a microfluidic system |
US20050220644A1 (en) * | 2004-03-31 | 2005-10-06 | Sebastian Bohm | Pneumatic actuator for bolus generation in a fluid handling circuit |
US7156117B2 (en) * | 2004-03-31 | 2007-01-02 | Lifescan Scotland Limited | Method of controlling the movement of fluid through a microfluidic circuit using an array of triggerable passive valves |
US20050217742A1 (en) * | 2004-03-31 | 2005-10-06 | Sebastian Bohm | Microfluidic circuit including an array of triggerable passive valves |
US7059352B2 (en) * | 2004-03-31 | 2006-06-13 | Lifescan Scotland | Triggerable passive valve for use in controlling the flow of fluid |
US20050220630A1 (en) * | 2004-03-31 | 2005-10-06 | Sebastian Bohm | Method of using triggerable passive valves to control the flow of fluid |
US7351213B2 (en) | 2004-04-15 | 2008-04-01 | Roche Diagnostics Operation, Inc. | Integrated spot monitoring device with fluid sensor |
US20050284773A1 (en) * | 2004-06-29 | 2005-12-29 | Allen John J | Method of preventing reuse in an analyte measuring system |
US20070027383A1 (en) * | 2004-07-01 | 2007-02-01 | Peyser Thomas A | Patches, systems, and methods for non-invasive glucose measurement |
KR20070043768A (en) * | 2004-07-01 | 2007-04-25 | 비보메디칼 인코포레이티드 | Non-invasive glucose measurement |
CN100395544C (en) * | 2004-08-02 | 2008-06-18 | 大金工业株式会社 | Oxygen electrodes |
GB0420256D0 (en) | 2004-09-13 | 2004-10-13 | Cassells John M | Method and apparatus for sampling and analysis of fluids |
US20060095225A1 (en) | 2004-11-02 | 2006-05-04 | Kirk Harmon | Method and computer program for pattern analysis and reporting of chronic disease state management data |
EP1654985A1 (en) * | 2004-11-09 | 2006-05-10 | F. Hoffmann-La Roche Ag | Sampling device for sample liquid |
US9743862B2 (en) | 2011-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Systems and methods for transcutaneously implanting medical devices |
US9259175B2 (en) * | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
US9572534B2 (en) | 2010-06-29 | 2017-02-21 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US10226207B2 (en) | 2004-12-29 | 2019-03-12 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
US7883464B2 (en) | 2005-09-30 | 2011-02-08 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
US9398882B2 (en) | 2005-09-30 | 2016-07-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor and data processing device |
US20090105569A1 (en) | 2006-04-28 | 2009-04-23 | Abbott Diabetes Care, Inc. | Introducer Assembly and Methods of Use |
US8613703B2 (en) | 2007-05-31 | 2013-12-24 | Abbott Diabetes Care Inc. | Insertion devices and methods |
US7731657B2 (en) | 2005-08-30 | 2010-06-08 | Abbott Diabetes Care Inc. | Analyte sensor introducer and methods of use |
US8571624B2 (en) | 2004-12-29 | 2013-10-29 | Abbott Diabetes Care Inc. | Method and apparatus for mounting a data transmission device in a communication system |
US20090082693A1 (en) * | 2004-12-29 | 2009-03-26 | Therasense, Inc. | Method and apparatus for providing temperature sensor module in a data communication system |
US8333714B2 (en) | 2006-09-10 | 2012-12-18 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US9788771B2 (en) | 2006-10-23 | 2017-10-17 | Abbott Diabetes Care Inc. | Variable speed sensor insertion devices and methods of use |
US7697967B2 (en) | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US7935063B2 (en) * | 2005-03-02 | 2011-05-03 | Roche Diagnostics Operations, Inc. | System and method for breaking a sterility seal to engage a lancet |
US7955271B2 (en) | 2006-10-13 | 2011-06-07 | Roche Diagnostics Operations, Inc. | Tape transport lance sampler |
CA2601441A1 (en) | 2005-03-21 | 2006-09-28 | Abbott Diabetes Care Inc. | Method and system for providing integrated medication infusion and analyte monitoring system |
US8280476B2 (en) * | 2005-03-29 | 2012-10-02 | Arkal Medical, Inc. | Devices, systems, methods and tools for continuous glucose monitoring |
GB2425601B (en) | 2005-04-26 | 2008-01-30 | Bio Nano Sensium Technologies | Sensor configuration |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
KR101381331B1 (en) | 2005-05-09 | 2014-04-04 | 테라노스, 인코포레이티드 | Point-of-care fluidic systems and uses thereof |
US7768408B2 (en) | 2005-05-17 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
US7620437B2 (en) | 2005-06-03 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
EP1759633A1 (en) * | 2005-09-01 | 2007-03-07 | F.Hoffmann-La Roche Ag | Device for sampling bodily fluids and its fabrication method |
US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
US7756561B2 (en) | 2005-09-30 | 2010-07-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
US7887494B2 (en) * | 2005-09-30 | 2011-02-15 | Intuity Medical, Inc. | Fluid sample transport devices and methods |
US8057404B2 (en) * | 2005-10-12 | 2011-11-15 | Panasonic Corporation | Blood sensor, blood testing apparatus, and method for controlling blood testing apparatus |
EP1950567B1 (en) | 2005-10-18 | 2016-05-18 | Fujimori Kogyo Co., Ltd. | Apparatus for monitoring thrombus formation and method of monitoring thrombus formation |
US7583190B2 (en) | 2005-10-31 | 2009-09-01 | Abbott Diabetes Care Inc. | Method and apparatus for providing data communication in data monitoring and management systems |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
WO2007054850A2 (en) * | 2005-11-09 | 2007-05-18 | Koninklijke Philips Electronics N.V. | Device for testing a fluid |
CA2636034A1 (en) | 2005-12-28 | 2007-10-25 | Abbott Diabetes Care Inc. | Medical device insertion |
US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
WO2007089777A2 (en) * | 2006-01-31 | 2007-08-09 | University Of Chicago | Method and apparatus for assaying blood clotting |
US8344966B2 (en) | 2006-01-31 | 2013-01-01 | Abbott Diabetes Care Inc. | Method and system for providing a fault tolerant display unit in an electronic device |
US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
GB0605003D0 (en) * | 2006-03-13 | 2006-04-19 | Microsample Ltd | Method and apparatus for piercing the skin and delivery or collection of liquids |
US8741230B2 (en) * | 2006-03-24 | 2014-06-03 | Theranos, Inc. | Systems and methods of sample processing and fluid control in a fluidic system |
US11287421B2 (en) | 2006-03-24 | 2022-03-29 | Labrador Diagnostics Llc | Systems and methods of sample processing and fluid control in a fluidic system |
US20080154107A1 (en) * | 2006-12-20 | 2008-06-26 | Jina Arvind N | Device, systems, methods and tools for continuous glucose monitoring |
US20100049021A1 (en) * | 2006-03-28 | 2010-02-25 | Jina Arvind N | Devices, systems, methods and tools for continuous analyte monitoring |
US20090131778A1 (en) * | 2006-03-28 | 2009-05-21 | Jina Arvind N | Devices, systems, methods and tools for continuous glucose monitoring |
US20090093735A1 (en) * | 2006-03-29 | 2009-04-09 | Stephan Korner | Test unit and test system for analyzing body fluids |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US7824333B2 (en) * | 2006-03-31 | 2010-11-02 | Lifescan, Inc. | Diabetes management methods and systems |
US7837941B2 (en) * | 2006-04-07 | 2010-11-23 | Agamatrix, Inc. | Method and apparatus for monitoring alteration of flow characteristics in a liquid sample |
US20070285651A1 (en) * | 2006-04-24 | 2007-12-13 | Cantor Thomas L | Methods and devices for measuring sample coagulation |
US8007999B2 (en) | 2006-05-10 | 2011-08-30 | Theranos, Inc. | Real-time detection of influenza virus |
US20070276211A1 (en) * | 2006-05-26 | 2007-11-29 | Jose Mir | Compact minimally invasive biomedical monitor |
US7920907B2 (en) | 2006-06-07 | 2011-04-05 | Abbott Diabetes Care Inc. | Analyte monitoring system and method |
US20100100005A1 (en) * | 2006-07-11 | 2010-04-22 | Infotonics Technology Center, Inc. | Minimally invasive allergy testing system with coated allergens |
EP1878386A1 (en) * | 2006-07-15 | 2008-01-16 | Roche Diagnostics GmbH | Process to produce lancet; lancet, lancet band and device for pricking the skin |
CA2659152C (en) * | 2006-07-17 | 2015-11-03 | Universal Biosensors Pty Ltd | Electrochemical detection of magnetic particle mobility |
US7674616B2 (en) * | 2006-09-14 | 2010-03-09 | Hemosense, Inc. | Device and method for measuring properties of a sample |
US8012744B2 (en) | 2006-10-13 | 2011-09-06 | Theranos, Inc. | Reducing optical interference in a fluidic device |
US8852124B2 (en) * | 2006-10-13 | 2014-10-07 | Roche Diagnostics Operations, Inc. | Tape transport lance sampler |
ATE430514T1 (en) * | 2006-10-14 | 2009-05-15 | Hoffmann La Roche | LANCET WITH CAPILLARY CHANNEL |
US8579853B2 (en) | 2006-10-31 | 2013-11-12 | Abbott Diabetes Care Inc. | Infusion devices and methods |
US8827945B2 (en) | 2006-11-06 | 2014-09-09 | Aardvark Medical, Inc. | Irrigation and aspiration devices and methods |
US20080113391A1 (en) | 2006-11-14 | 2008-05-15 | Ian Gibbons | Detection and quantification of analytes in bodily fluids |
US8979755B2 (en) * | 2006-12-08 | 2015-03-17 | The Boeing Company | Devices and systems for remote physiological monitoring |
JP2008185564A (en) * | 2007-01-31 | 2008-08-14 | Fujimori Kogyo Co Ltd | Inspection method and device for blood coagulation ability |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US20080234562A1 (en) * | 2007-03-19 | 2008-09-25 | Jina Arvind N | Continuous analyte monitor with multi-point self-calibration |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US20080297169A1 (en) * | 2007-05-31 | 2008-12-04 | Greenquist Alfred C | Particle Fraction Determination of A Sample |
US20080312518A1 (en) * | 2007-06-14 | 2008-12-18 | Arkal Medical, Inc | On-demand analyte monitor and method of use |
US20090025459A1 (en) * | 2007-07-23 | 2009-01-29 | Cardiac Pacemakers, Inc. | Implantable viscosity monitoring device and method therefor |
KR100885074B1 (en) * | 2007-07-26 | 2009-02-25 | 주식회사 아이센스 | Microfluidic sensor complex structures |
WO2009015390A2 (en) * | 2007-07-26 | 2009-01-29 | University Of Chicago | Co-incuating confined microbial communities |
US8158430B1 (en) | 2007-08-06 | 2012-04-17 | Theranos, Inc. | Systems and methods of fluidic sample processing |
US8328720B2 (en) * | 2007-08-10 | 2012-12-11 | Infotonics Technology Center, Inc. | MEMS interstitial prothrombin time test |
EP2040073A1 (en) * | 2007-09-20 | 2009-03-25 | Iline Microsystems, S.L. | Microfluidic device and method for fluid clotting time determination |
US8192360B2 (en) * | 2007-09-25 | 2012-06-05 | Pacesetter, Inc. | Implantable body fluid analyzer |
EP2201136B1 (en) | 2007-10-01 | 2017-12-06 | Nabsys 2.0 LLC | Nanopore sequencing by hybridization of probes to form ternary complexes and variable range alignment |
CN103323610B (en) | 2007-10-02 | 2016-12-28 | 赛拉诺斯股份有限公司 | Modular point-of-care devices and application thereof |
EP2053387A1 (en) * | 2007-10-22 | 2009-04-29 | Centre National de la Recherche Scientifique | Test device for platelet aggregation detection |
US20100280499A1 (en) * | 2007-12-26 | 2010-11-04 | Ofer Yodfat | System and method for glycemic control |
US7766846B2 (en) | 2008-01-28 | 2010-08-03 | Roche Diagnostics Operations, Inc. | Rapid blood expression and sampling |
US20090247856A1 (en) * | 2008-03-28 | 2009-10-01 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
DE102008022884A1 (en) * | 2008-05-08 | 2009-11-12 | Zander, Rolf, Prof. Dr.Med. | Device and method for blood coagulation diagnostics |
JP2011522616A (en) * | 2008-06-04 | 2011-08-04 | セブンス センス バイオシステムズ,インコーポレーテッド | Compositions and methods for single-step diagnosis |
WO2009149257A1 (en) | 2008-06-04 | 2009-12-10 | The University Of Chicago | The chemistrode: a plug-based microfluidic device and method for stimulation and sampling with high temporal, spatial, and chemical resolution |
ES2349390T3 (en) * | 2008-06-05 | 2010-12-30 | F. Hoffmann-La Roche Ag | METHOD FOR DETERMINING AN ANALYTE IN A LIQUID SAMPLE AND ANALYSIS DEVICE. |
KR100976149B1 (en) | 2008-06-25 | 2010-08-16 | (주)바이오버드 | Methods for Preparing Nano-Patterned Epoxy Templates |
GB0811874D0 (en) * | 2008-06-30 | 2008-07-30 | Nemaura Pharma Ltd | Patches for reverse iontophoresis |
ES2451541T3 (en) | 2008-07-16 | 2014-03-27 | International Technidyne Corporation | Device based on cuvette for measurement and testing of blood coagulation |
WO2010018833A1 (en) * | 2008-08-11 | 2010-02-18 | 藤森工業株式会社 | Blood-platelet test method and blood-platelet test device |
EP2342362B1 (en) | 2008-09-03 | 2017-03-01 | Nabsys 2.0 LLC | Use of longitudinally displaced nanoscale electrodes for voltage sensing of biomolecules and other analytes in fluidic channels |
US8262879B2 (en) | 2008-09-03 | 2012-09-11 | Nabsys, Inc. | Devices and methods for determining the length of biopolymers and distances between probes bound thereto |
US9650668B2 (en) | 2008-09-03 | 2017-05-16 | Nabsys 2.0 Llc | Use of longitudinally displaced nanoscale electrodes for voltage sensing of biomolecules and other analytes in fluidic channels |
WO2010070461A1 (en) * | 2008-12-16 | 2010-06-24 | Koninklijke Philips Electronics N. V. | Hydrophobic valve |
US8448499B2 (en) | 2008-12-23 | 2013-05-28 | C A Casyso Ag | Cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method |
JP6052267B2 (en) * | 2009-01-08 | 2016-12-27 | ソニー株式会社 | Blood coagulation system analyzer, blood coagulation system analysis method and program |
JP5691168B2 (en) * | 2009-01-08 | 2015-04-01 | ソニー株式会社 | Blood coagulation system analyzer, blood coagulation system analysis method and program |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US8560082B2 (en) | 2009-01-30 | 2013-10-15 | Abbott Diabetes Care Inc. | Computerized determination of insulin pump therapy parameters using real time and retrospective data processing |
DK2391892T3 (en) | 2009-01-30 | 2017-04-24 | Mycartis N V | BIOMARKET FOR DIAGNOSIS, PREDICTION AND / OR PROJECTS OF ACUTE HEART FAILURE AND USE thereof |
US20100198034A1 (en) | 2009-02-03 | 2010-08-05 | Abbott Diabetes Care Inc. | Compact On-Body Physiological Monitoring Devices and Methods Thereof |
US8696917B2 (en) * | 2009-02-09 | 2014-04-15 | Edwards Lifesciences Corporation | Analyte sensor and fabrication methods |
JP6078230B2 (en) | 2009-03-02 | 2017-02-08 | セブンス センス バイオシステムズ,インコーポレーテッド | Techniques and devices related to blood sampling |
US9119578B2 (en) | 2011-04-29 | 2015-09-01 | Seventh Sense Biosystems, Inc. | Plasma or serum production and removal of fluids under reduced pressure |
US9033898B2 (en) | 2010-06-23 | 2015-05-19 | Seventh Sense Biosystems, Inc. | Sampling devices and methods involving relatively little pain |
US9041541B2 (en) | 2010-01-28 | 2015-05-26 | Seventh Sense Biosystems, Inc. | Monitoring or feedback systems and methods |
US9295417B2 (en) | 2011-04-29 | 2016-03-29 | Seventh Sense Biosystems, Inc. | Systems and methods for collecting fluid from a subject |
AU2010229490B2 (en) | 2009-03-24 | 2015-02-12 | University Of Chicago | Slip chip device and methods |
US10196700B2 (en) | 2009-03-24 | 2019-02-05 | University Of Chicago | Multivolume devices, kits and related methods for quantification and detection of nucleic acids and other analytes |
US9464319B2 (en) | 2009-03-24 | 2016-10-11 | California Institute Of Technology | Multivolume devices, kits and related methods for quantification of nucleic acids and other analytes |
US9447461B2 (en) | 2009-03-24 | 2016-09-20 | California Institute Of Technology | Analysis devices, kits, and related methods for digital quantification of nucleic acids and other analytes |
BRPI1006722A2 (en) | 2009-04-09 | 2017-10-10 | Entegrion Inc | "method of preparing dehydrated blood products, dehydrated blood products, bandage or surgical aids, method for preparing dehydrated fixed blood platelets, dehydrated fixed blood platelets, method for treating a patient suffering from a blood disorder and dry fixed blood platelets" by atomization having geometry with spherical cavities " |
WO2010122158A1 (en) | 2009-04-23 | 2010-10-28 | Dublin City University | A lateral flow assay device for coagulation monitoring and method thereof |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
WO2010129375A1 (en) | 2009-04-28 | 2010-11-11 | Abbott Diabetes Care Inc. | Closed loop blood glucose control algorithm analysis |
WO2010138136A1 (en) * | 2009-05-28 | 2010-12-02 | Nabsys, Inc. | Devices and methods for determining the length of biopolymers and distances between probes bound thereto |
WO2010138856A1 (en) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
EP2456351B1 (en) | 2009-07-23 | 2016-10-12 | Abbott Diabetes Care, Inc. | Real time management of data relating to physiological control of glucose levels |
WO2011026148A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
CA2765712A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Medical devices and methods |
WO2011026147A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US9320461B2 (en) | 2009-09-29 | 2016-04-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
WO2011041531A1 (en) | 2009-09-30 | 2011-04-07 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US8862448B2 (en) | 2009-10-19 | 2014-10-14 | Theranos, Inc. | Integrated health data capture and analysis system |
WO2011048168A1 (en) | 2009-10-21 | 2011-04-28 | Pronota N.V. | Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof |
WO2011048200A2 (en) * | 2009-10-22 | 2011-04-28 | Roche Diagnostics Gmbh | Micro-capillary system having increased sample volume |
EP3257442A3 (en) * | 2009-10-30 | 2018-05-09 | Seventh Sense Biosystems, Inc. | Relatively small devices applied to the skin, modular systems, and methods of use thereof |
CA2780492C (en) * | 2009-12-18 | 2018-07-17 | Entegrion, Inc. | Portable coagulation monitoring device and method of assessing coagulation response |
US10739358B2 (en) | 2009-12-18 | 2020-08-11 | Entegrion, Inc. | Portable coagulation monitoring devices, systems, and methods |
US20110165037A1 (en) * | 2010-01-07 | 2011-07-07 | Ismagilov Rustem F | Interfaces that eliminate non-specific adsorption, and introduce specific interactions |
EP3243435A1 (en) * | 2010-01-13 | 2017-11-15 | Seventh Sense Biosystems, Inc. | Sampling device interfaces |
DE102010000843A1 (en) * | 2010-01-13 | 2011-07-14 | Robert Bosch GmbH, 70469 | Porous micro-needle assembly glucose sensor device, corresponding manufacturing method and glucose measurement method |
USD924406S1 (en) | 2010-02-01 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
JP5752055B2 (en) | 2010-02-10 | 2015-07-22 | 藤森工業株式会社 | Platelet testing microchip and platelet testing apparatus using the same |
JP5840120B2 (en) * | 2010-03-03 | 2016-01-06 | 日本化薬株式会社 | Detection device |
CA3135001A1 (en) * | 2010-03-24 | 2011-09-29 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
EP2553461B1 (en) | 2010-03-26 | 2016-01-20 | Mycartis N.V. | Ltbp2 as a biomarker for renal dysfunction and glomerular filtration rate |
TWI461689B (en) * | 2010-04-01 | 2014-11-21 | Univ Nat Cheng Kung | Biomedical chip comprising dry powder reagent for blood coagulation test |
DK2555704T3 (en) | 2010-04-08 | 2019-08-05 | Hemosonics Llc | VIEW OF HEMOSTATIC PARAMETERS |
WO2011128357A2 (en) | 2010-04-13 | 2011-10-20 | Pronota N.V. | Biomarkers for hypertensive disorders of pregnancy |
JP5723680B2 (en) * | 2010-06-02 | 2015-05-27 | 積水化学工業株式会社 | Method for measuring substances |
ES2694080T3 (en) | 2010-06-09 | 2018-12-17 | Apex Biotechnology Corp. | Device and method for measuring prothrombin time and hematocrit by analyzing the reactance change in a sample |
US11064921B2 (en) | 2010-06-29 | 2021-07-20 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US20120016308A1 (en) | 2010-07-16 | 2012-01-19 | Seventh Sense Biosystems, Inc. | Low-pressure packaging for fluid devices |
US20130158482A1 (en) | 2010-07-26 | 2013-06-20 | Seventh Sense Biosystems, Inc. | Rapid delivery and/or receiving of fluids |
WO2012021801A2 (en) | 2010-08-13 | 2012-02-16 | Seventh Sense Biosystems, Inc. | Systems and techniques for monitoring subjects |
KR101221296B1 (en) | 2010-08-18 | 2013-01-10 | 연세대학교 산학협력단 | Blood Coagulation Measuring Device and Method of Synthesizing the Same |
JP5549484B2 (en) * | 2010-09-01 | 2014-07-16 | ソニー株式会社 | Sample cartridge and apparatus for measuring electrical properties of liquid samples |
US8715933B2 (en) | 2010-09-27 | 2014-05-06 | Nabsys, Inc. | Assay methods using nicking endonucleases |
EP2992827B1 (en) | 2010-11-09 | 2017-04-19 | Seventh Sense Biosystems, Inc. | Systems and interfaces for blood sampling |
US8859201B2 (en) | 2010-11-16 | 2014-10-14 | Nabsys, Inc. | Methods for sequencing a biomolecule by detecting relative positions of hybridized probes |
CN106323876B (en) | 2011-01-21 | 2020-02-14 | 西拉诺斯知识产权有限责任公司 | System and method for maximizing sample usage |
EP2676143B1 (en) | 2011-02-15 | 2023-11-01 | Hemosonics, Llc | Characterization of blood hemostasis and oxygen transport parameters |
US9272280B2 (en) | 2011-02-15 | 2016-03-01 | Hemosonics Llc | Device, systems and methods for evaluation of hemostasis |
DE102011006349A1 (en) * | 2011-03-29 | 2012-10-04 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Device and method for detecting, measuring and / or influencing the clotting of blood systems |
US10244981B2 (en) | 2011-03-30 | 2019-04-02 | SensiVida Medical Technologies, Inc. | Skin test image analysis apparatuses and methods thereof |
EP2701600B1 (en) | 2011-04-29 | 2016-06-08 | Seventh Sense Biosystems, Inc. | Delivering and/or receiving fluids |
US20130158468A1 (en) | 2011-12-19 | 2013-06-20 | Seventh Sense Biosystems, Inc. | Delivering and/or receiving material with respect to a subject surface |
EP2520225B1 (en) | 2011-05-06 | 2014-05-21 | Roche Diagnostics GmbH | Lancet |
WO2012159021A2 (en) | 2011-05-19 | 2012-11-22 | Hemosonics, Llc | Portable hemostasis analyzer |
CN102818822B (en) * | 2011-06-09 | 2015-08-12 | 五鼎生物技术股份有限公司 | To utilize in analyzing samples reactance change to measure diagnostic device and the method for prothrombin time and hematocrit ratio (HCT%) |
WO2013020045A2 (en) * | 2011-08-03 | 2013-02-07 | Coentre Ventures Llc | Cloud calibration of a test device |
KR101193566B1 (en) * | 2011-08-10 | 2012-10-22 | 고려대학교 산학협력단 | Apparatus of platelet multi-function analysis based on micro-chip |
US9619627B2 (en) | 2011-09-25 | 2017-04-11 | Theranos, Inc. | Systems and methods for collecting and transmitting assay results |
JP6443802B2 (en) | 2011-11-07 | 2018-12-26 | アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. | Analyte monitoring apparatus and method |
EP4344633A2 (en) | 2011-12-11 | 2024-04-03 | Abbott Diabetes Care, Inc. | Analyte sensor methods |
KR101363812B1 (en) * | 2011-12-27 | 2014-02-20 | 고려대학교 산학협력단 | Bleeding time measurement apparatus and method by using blood migration ratio |
TWI498558B (en) * | 2012-01-20 | 2015-09-01 | Univ Nat Cheng Kung | Device for detecting blood coagulation and manufacturing method thereof |
AU2013243541B2 (en) * | 2012-04-04 | 2017-04-06 | United States Of America As Represented By The Secretary Of The Air Force | Sweat simulation, collection and sensing systems |
ITUD20120079A1 (en) * | 2012-05-04 | 2013-11-05 | Ct Di Riferimento Oncologico | METHOD FOR ANALYSIS OF THE AGGREGATE FORMATION PROCESS IN A BIOLOGICAL AND RELATIVE FLUID ANALYSIS EQUIPMENT |
US20140317954A1 (en) * | 2012-05-10 | 2014-10-30 | Norgren Automation Solutions, Llc | Method and apparatus for automatically drying wet floors |
US9274081B2 (en) * | 2012-07-16 | 2016-03-01 | Genefluidics, Inc. | Sample dependent selection of parameters for use in electrokinetic treatment of the sample |
EP3970738A1 (en) | 2012-07-25 | 2022-03-23 | Bioverativ Therapeutics Inc. | Blood factor monitoring assay and uses thereof |
KR20150042225A (en) * | 2012-08-01 | 2015-04-20 | 요파이메터 엘엘씨 | User interface for analyte monitoring systems |
WO2014025881A2 (en) * | 2012-08-07 | 2014-02-13 | Old Dominion University Reasearch Foundation | A polymer-based microfluidic resistive sensor for detecting distributed loads, methods, and processes for fabricating the same |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
JP2014115256A (en) | 2012-12-12 | 2014-06-26 | Sony Corp | Container for electrical measurement, apparatus for electrical measurement, and method for electrical measurement |
US9636060B2 (en) | 2012-12-18 | 2017-05-02 | Abbott Diabetes Care Inc. | Dermal layer analyte sensing devices and methods |
US9914966B1 (en) | 2012-12-20 | 2018-03-13 | Nabsys 2.0 Llc | Apparatus and methods for analysis of biomolecules using high frequency alternating current excitation |
EP2956550B1 (en) | 2013-01-18 | 2020-04-08 | Nabsys 2.0 LLC | Enhanced probe binding |
US9668686B2 (en) | 2013-03-15 | 2017-06-06 | Abbott Diabetes Care Inc. | In vivo glucose sensing in an increased perfusion dermal layer |
EP3418390A1 (en) | 2013-05-14 | 2018-12-26 | Struszym S.L. | Test strips for determining coagulation factor activities |
DE102013017317A1 (en) * | 2013-10-18 | 2015-04-23 | Endress + Hauser Flowtec Ag | Measuring arrangement with a carrier element and a sensor |
EP3069135A4 (en) * | 2013-11-15 | 2017-08-30 | Entegrion, Inc. | Portable coagulation monitoring devices, systems, and methods |
US20150140671A1 (en) * | 2013-11-18 | 2015-05-21 | Johnson Electric S.A. | Method and system for assembling a microfluidic sensor |
US20150182157A1 (en) * | 2013-12-30 | 2015-07-02 | CardioCanary, Inc. | On-Patient Autonomous Blood Sampler and Analyte Measurement Device |
US11229382B2 (en) | 2013-12-31 | 2022-01-25 | Abbott Diabetes Care Inc. | Self-powered analyte sensor and devices using the same |
JP6332786B2 (en) * | 2014-02-14 | 2018-05-30 | 株式会社ライトニックス | Medical needle and puncture device |
WO2015127413A1 (en) * | 2014-02-24 | 2015-08-27 | Mocon, Inc. | Rugged target-analyte permeation testing instrument employing a consolidating block manifold |
CN103919616B (en) * | 2014-05-06 | 2016-03-23 | 苏州大学 | A kind of device for artificial organ surface Hemostasis examination and detection method |
EP2974656A1 (en) * | 2014-07-14 | 2016-01-20 | Universität Zürich | Device for measuring the concentration of an analyte in the blood or tissue of an animal or a human, particularly a premature infant, in a self-calibrating manner |
EP3191836B1 (en) | 2014-09-09 | 2022-11-23 | Perosphere Technologies Inc. | Microfluid chip-based, universal coagulation assay |
US9561184B2 (en) | 2014-09-19 | 2017-02-07 | Velico Medical, Inc. | Methods and systems for multi-stage drying of plasma |
US10175225B2 (en) | 2014-09-29 | 2019-01-08 | C A Casyso Ag | Blood testing system and method |
KR101571467B1 (en) * | 2014-11-21 | 2015-11-24 | 한국과학기술연구원 | Apparatus for collecting tear |
US10987039B2 (en) | 2014-12-03 | 2021-04-27 | Stmicroelectronics S.R.L. | Microneedle array device and method of making |
JP6443954B2 (en) * | 2015-01-30 | 2018-12-26 | ヒューレット−パッカード デベロップメント カンパニー エル.ピー.Hewlett‐Packard Development Company, L.P. | Microfluidic chip for coagulation detection |
US10378098B2 (en) | 2015-03-18 | 2019-08-13 | Materion Corporation | Methods for optimized production of multilayer metal/transparent conducting oxide (TCO) constructs |
US10197522B2 (en) | 2015-03-18 | 2019-02-05 | Materion Corporation | Multilayer constructs for metabolite strips providing inert surface and mechanical advantage |
WO2016183493A1 (en) | 2015-05-14 | 2016-11-17 | Abbott Diabetes Care Inc. | Compact medical device inserters and related systems and methods |
US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
EP3324835A4 (en) * | 2015-07-24 | 2019-02-27 | University of Cincinnati | Reduced sample volume for sensing of analytes generated by reverse iontophoresis |
CN105628747B (en) * | 2015-12-18 | 2019-03-22 | 上海奥普生物医药有限公司 | Clotting time device for testing and analyzing and its method for testing and analyzing |
KR20180103944A (en) * | 2016-01-15 | 2018-09-19 | 케이스 웨스턴 리저브 유니버시티 | Dielectric Sensing for Sample Characterization |
WO2017123266A1 (en) * | 2016-01-16 | 2017-07-20 | Hewlett-Packard Development Company, L.P. | Blood characteristic measurement |
US11073490B2 (en) * | 2016-02-05 | 2021-07-27 | Sensor Health S.r.l. | Measuring device for blood and/or liquid interstitial analytes |
WO2017139084A1 (en) * | 2016-02-11 | 2017-08-17 | Applied Materials, Inc. | Medical bodily fluid sampling device |
JP6070892B2 (en) * | 2016-08-08 | 2017-02-01 | ソニー株式会社 | Electrical measurement container, electrical measurement device, and electrical measurement method |
CN106153439B (en) * | 2016-08-16 | 2019-02-01 | 中国科学院苏州生物医学工程技术研究所 | Hemostasis detestion device |
KR101910932B1 (en) * | 2016-08-31 | 2018-10-23 | 이오플로우(주) | Electoosmotic pump |
US10473674B2 (en) * | 2016-08-31 | 2019-11-12 | C A Casyso Gmbh | Controlled blood delivery to mixing chamber of a blood testing cartridge |
US10653349B2 (en) * | 2016-10-18 | 2020-05-19 | International Business Machines Corporation | Diagnostic apparatus |
US20180164281A1 (en) * | 2016-12-13 | 2018-06-14 | Dbs System Sa | Device and Method for Detecting the Deposition of a Biological Liquid Sample on a Substrate |
JP6414234B2 (en) * | 2017-01-05 | 2018-10-31 | ソニー株式会社 | Electrical measurement container, electrical measurement device, and electrical measurement method |
JP6962338B2 (en) * | 2017-01-06 | 2021-11-05 | ソニーグループ株式会社 | Blood coagulation system analyzer, blood coagulation system analysis system, blood coagulation system analysis method, and blood coagulation system analysis program, and bleeding amount prediction device, bleeding amount prediction system, bleeding amount prediction method, and bleeding amount prediction program |
CN115444410A (en) | 2017-01-23 | 2022-12-09 | 雅培糖尿病护理公司 | Applicator and assembly for inserting an in vivo analyte sensor |
EP3582893B1 (en) | 2017-04-20 | 2021-03-31 | Hewlett-Packard Development Company, L.P. | Microfluidic reaction system |
CA3065331A1 (en) | 2017-04-20 | 2018-10-25 | Hemosonics, Llc | Disposable system for analysis of hemostatic function |
WO2018194665A1 (en) | 2017-04-21 | 2018-10-25 | Hewlett-Packard Development Company, L.P. | Microfluidic chip |
EP3582892A4 (en) | 2017-04-21 | 2020-03-04 | Hewlett-Packard Development Company, L.P. | Coplanar microfluidic manipulation |
WO2018194651A1 (en) | 2017-04-21 | 2018-10-25 | Hewlett-Packard Development Company, | Coplanar fluidic interconnect |
EP3583416A4 (en) | 2017-04-21 | 2020-03-18 | Hewlett-Packard Development Company, L.P. | Chip to chip fluidic interconnect |
CN107144697A (en) * | 2017-05-15 | 2017-09-08 | 银翮蔚蓝健康产业研究院(南京)有限公司 | Clotting time monitoring device and method |
CN107036738A (en) * | 2017-06-01 | 2017-08-11 | 黄昱 | A kind of blood platelet Micro-force sensor of the elastic film variable capacitance based on nanometer technique |
JP6938685B2 (en) * | 2017-06-02 | 2021-09-22 | ノースウェスタン ユニヴァーシティNorthwestern University | Microfluidic system for epidermis sampling and sensing |
EP3639018A1 (en) | 2017-06-11 | 2020-04-22 | Epymetrics AG | Chip-based multi-channel electrochemical transducer and method of use thereof |
US20210231656A1 (en) * | 2017-08-13 | 2021-07-29 | Mao Foodtech, Ltd. | System, Device, and Method for Identifying and Monitoring Breast Milk Composition |
EP3678732A4 (en) * | 2017-09-07 | 2021-05-12 | The Regents of the University of California | Multiplexed sweat extraction and sensing wearable device for normalized and time-sequential sweat analysis |
WO2019190596A1 (en) * | 2017-10-20 | 2019-10-03 | Rutgers, The State University Of New Jersey | Transcutaneous wearable apparatus for continuous monitoring of biomarkers in blood |
CN109839349B (en) * | 2017-11-28 | 2021-12-07 | 北京碧澄生物科技有限公司 | Device and method for detecting liquid phase change |
WO2019118420A1 (en) * | 2017-12-11 | 2019-06-20 | Stc. Unm | Mild traumatic brain injury diagnostic immunochromatographic microneedle patch |
SE541788C2 (en) * | 2017-12-22 | 2019-12-17 | Brighter Ab Publ | Skin patch for diagnosis comprising an evaporation layer |
GB2569956B (en) * | 2018-01-03 | 2021-07-14 | Bae Systems Plc | Viscometer device |
WO2019170776A1 (en) * | 2018-03-06 | 2019-09-12 | Xsensio SA | System for collection and analysis of biofluid from skin and method of using the same |
CN108398470B (en) * | 2018-04-13 | 2024-01-30 | 广州万孚生物技术股份有限公司 | Biosensor for measuring blood activation clotting time and manufacturing method thereof |
CN110755088B (en) * | 2018-07-27 | 2022-07-26 | 华广生技股份有限公司 | Elastic physiological paster |
FR3084578B1 (en) * | 2018-08-03 | 2024-01-12 | Pkvitality | MANAGEMENT OF MICRONEEDLE INVESTMENT |
JP6791220B2 (en) * | 2018-09-18 | 2020-11-25 | ソニー株式会社 | Electrical measuring container, electrical measuring device and electrical measuring method |
WO2020117709A1 (en) | 2018-12-02 | 2020-06-11 | Polymer Technology Systems, Inc. | Systems and methods for a combined strip detection and heating system in an electrochemical test strip |
CN109632571A (en) * | 2019-01-29 | 2019-04-16 | 深圳市华星光电半导体显示技术有限公司 | Solution level measuring device and method |
CN110057890B (en) * | 2019-03-26 | 2021-07-30 | 中国科学院苏州生物医学工程技术研究所 | Blood coagulation detection chip and electrochemical sensor |
USD1002852S1 (en) | 2019-06-06 | 2023-10-24 | Abbott Diabetes Care Inc. | Analyte sensor device |
EP3753485A1 (en) * | 2019-06-20 | 2020-12-23 | Nokia Technologies Oy | Electrode apparatuses and methods of forming electrode apparatuses |
CN111803204B (en) * | 2019-07-08 | 2022-07-01 | 昆山雷盛医疗科技有限公司 | Radio frequency thermal ablation system and control method thereof |
WO2021016140A1 (en) * | 2019-07-19 | 2021-01-28 | Micropoint Bioscience, Inc. | Micro-assay cartridges |
US20240081724A1 (en) * | 2019-10-16 | 2024-03-14 | Jason Michael Strohmaier | Wearable point-of-care devices for assessing immune activity from interstitial fluid and methods of use thereof |
JP2023507406A (en) * | 2019-12-20 | 2023-02-22 | スリーエム イノベイティブ プロパティズ カンパニー | Multilayer adhesive fluid collection article containing capillary channels |
US20220003731A1 (en) * | 2020-07-06 | 2022-01-06 | Florida Atlantic University Board Of Trustees | Vascular occlusion testing device |
US20230212636A1 (en) * | 2020-08-03 | 2023-07-06 | The Regents Of The University Of Colorado, A Body Corporate | Method To Sense The Presence And Quantities Of Microbes Through The Use Of Transient Sensing Materials |
USD999913S1 (en) | 2020-12-21 | 2023-09-26 | Abbott Diabetes Care Inc | Analyte sensor inserter |
CN112842333A (en) * | 2020-12-31 | 2021-05-28 | 华中科技大学 | Visual glucose concentration detection microneedle patch, preparation method and application |
CN117479881A (en) * | 2021-04-14 | 2024-01-30 | 萨蒂奥股份有限公司 | Free standing skin patch for detection of physiological analytes |
CN113702649B (en) * | 2021-08-25 | 2022-09-02 | 常州工程职业技术学院 | Microfluid biochip for measuring blood coagulation time |
US11877848B2 (en) | 2021-11-08 | 2024-01-23 | Satio, Inc. | Dermal patch for collecting a physiological sample |
US11510602B1 (en) | 2021-11-08 | 2022-11-29 | Satio, Inc. | Dermal patch for collecting a physiological sample |
US11841189B1 (en) | 2022-09-15 | 2023-12-12 | Velico Medical, Inc. | Disposable for a spray drying system |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4873993A (en) * | 1986-07-22 | 1989-10-17 | Personal Diagnostics, Inc. | Cuvette |
WO1995010221A2 (en) * | 1993-10-09 | 1995-04-20 | Jakob Korf | Monitoring the concentration of a substance or a group of substances in a body fluid |
WO1995033504A1 (en) | 1994-06-06 | 1995-12-14 | The Regents Of The University Of California | Ic-processed microneedles |
WO1997019344A1 (en) * | 1995-11-22 | 1997-05-29 | Legacy Good Samaritan Hospital And Medical Center | Device for monitoring changes in analyte concentration |
US5801057A (en) | 1996-03-22 | 1998-09-01 | Smart; Wilson H. | Microsampling device and method of construction |
WO2000022977A1 (en) | 1998-10-19 | 2000-04-27 | Meinhard Knoll | Minimally invasive sensor system |
US6083196A (en) | 1997-12-11 | 2000-07-04 | Alza Corporation | Device for enhancing transdermal agent flux |
WO2000074766A1 (en) | 1999-06-09 | 2000-12-14 | The Procter & Gamble Company | Intracutaneous edged microneedle structure |
WO2001064105A1 (en) | 2000-03-02 | 2001-09-07 | Inverness Medical Technology, Inc. | Combined lancet and electrochemical analyte-testing apparatus |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1299363A (en) | 1968-09-27 | 1972-12-13 | Amiram Ur | Monitoring of chemical, bio-chemical and biological reactions, particularly blood-clotting |
US5164598A (en) * | 1985-08-05 | 1992-11-17 | Biotrack | Capillary flow device |
US4756884A (en) * | 1985-08-05 | 1988-07-12 | Biotrack, Inc. | Capillary flow device |
US4758884A (en) * | 1986-05-19 | 1988-07-19 | Kaiser Electronics | Electronically switched field sequential color video display having parallel color inputs |
CN87211253U (en) * | 1987-10-06 | 1988-06-08 | 上海市长海医院 | Micro-computer monitering system for sphygmogram hemodynamics |
AT393213B (en) * | 1989-02-08 | 1991-09-10 | Avl Verbrennungskraft Messtech | DEVICE FOR DETERMINING AT LEAST ONE MEDICAL MEASURING SIZE |
US5039617A (en) * | 1989-04-20 | 1991-08-13 | Biotrack, Inc. | Capillary flow device and method for measuring activated partial thromboplastin time |
US5109850A (en) * | 1990-02-09 | 1992-05-05 | Massachusetts Institute Of Technology | Automatic blood monitoring for medication delivery method and apparatus |
US5328847A (en) * | 1990-02-20 | 1994-07-12 | Case George D | Thin membrane sensor with biochemical switch |
US6156270A (en) * | 1992-05-21 | 2000-12-05 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
US5344754A (en) * | 1993-01-13 | 1994-09-06 | Avocet Medical, Inc. | Assay timed by electrical resistance change and test strip |
US5582184A (en) | 1993-10-13 | 1996-12-10 | Integ Incorporated | Interstitial fluid collection and constituent measurement |
US5548587A (en) * | 1994-09-12 | 1996-08-20 | Efficient Networks, Inc. | Asynchronous transfer mode adapter for desktop applications |
US5577499A (en) * | 1994-10-03 | 1996-11-26 | Teves; Leonides Y. | Blood analyzer |
US5504011A (en) * | 1994-10-21 | 1996-04-02 | International Technidyne Corporation | Portable test apparatus and associated method of performing a blood coagulation test |
US5879367A (en) | 1995-09-08 | 1999-03-09 | Integ, Inc. | Enhanced interstitial fluid collection |
US5708247A (en) | 1996-02-14 | 1998-01-13 | Selfcare, Inc. | Disposable glucose test strips, and methods and compositions for making same |
US6120460A (en) * | 1996-09-04 | 2000-09-19 | Abreu; Marcio Marc | Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions |
ATE227844T1 (en) * | 1997-02-06 | 2002-11-15 | Therasense Inc | SMALL VOLUME SENSOR FOR IN-VITRO DETERMINATION |
US6558351B1 (en) * | 1999-06-03 | 2003-05-06 | Medtronic Minimed, Inc. | Closed loop system for controlling insulin infusion |
US6046051A (en) * | 1997-06-27 | 2000-04-04 | Hemosense, Inc. | Method and device for measuring blood coagulation or lysis by viscosity changes |
EP0913791A1 (en) * | 1997-10-30 | 1999-05-06 | Navitas Co., Limited | Method for manufacturing card product and manufacturing apparatus therefor |
WO1999044507A1 (en) * | 1998-03-06 | 1999-09-10 | Spectrx, Inc. | Integrated tissue poration, fluid harvesting and analysis device, and method therefor |
AU754536B2 (en) * | 1998-03-19 | 2002-11-21 | Orgenics Biosensors Ltd. | Device for the determination of blood clotting by capacitance or resistance |
US7344499B1 (en) * | 1998-06-10 | 2008-03-18 | Georgia Tech Research Corporation | Microneedle device for extraction and sensing of bodily fluids |
MXPA01000698A (en) | 1998-07-21 | 2002-04-08 | Spectrx Inc | System and method for continuous analyte monitoring. |
EP1187653B1 (en) | 1999-06-04 | 2010-03-31 | Georgia Tech Research Corporation | Devices for enhanced microneedle penetration of biological barriers |
KR100500223B1 (en) | 1999-08-30 | 2005-07-11 | 니뽄 가이시 가부시키가이샤 | Corrugated wall honeycomb structure and production method thereof |
WO2001036666A1 (en) * | 1999-11-15 | 2001-05-25 | I-Stat Corporation | Apparatus and method for assaying coagulation in fluid samples |
DE10003507B4 (en) * | 2000-01-27 | 2004-06-03 | Knoll, Meinhard, Prof. Dr. | Device and method for the removal of liquids from the body's own tissue and determination of substance concentrations in this liquid |
AU2001245472A1 (en) * | 2000-03-09 | 2001-09-17 | Nanopass Ltd. | Systems and methods for the transport of fluids through a biological barrier andproduction techniques for such systems |
US6612111B1 (en) * | 2000-03-27 | 2003-09-02 | Lifescan, Inc. | Method and device for sampling and analyzing interstitial fluid and whole blood samples |
AU6501201A (en) * | 2000-06-01 | 2001-12-11 | Science Applic Int Corp | Systems and methods for monitoring health and delivering drugs transdermally |
US6540675B2 (en) * | 2000-06-27 | 2003-04-01 | Rosedale Medical, Inc. | Analyte monitor |
DE10052066A1 (en) | 2000-10-19 | 2002-05-29 | Inverness Medical Ltd | Screen printable paste for the production of a porous polymer membrane for a biosensor |
-
2000
- 2000-12-19 GB GBGB0030929.4A patent/GB0030929D0/en not_active Ceased
-
2001
- 2001-12-19 EP EP01271174.3A patent/EP1359837B1/en not_active Expired - Lifetime
- 2001-12-19 EP EP10182356.5A patent/EP2305102B1/en not_active Expired - Lifetime
- 2001-12-19 WO PCT/GB2001/005644 patent/WO2002050534A1/en active Application Filing
- 2001-12-19 AU AU2002222275A patent/AU2002222275A1/en not_active Abandoned
- 2001-12-19 CN CNB018227287A patent/CN100458441C/en not_active Expired - Fee Related
- 2001-12-19 CA CA002432535A patent/CA2432535A1/en not_active Abandoned
- 2001-12-19 DE DE60141252T patent/DE60141252D1/en not_active Expired - Lifetime
- 2001-12-19 AU AU2002222280A patent/AU2002222280A1/en not_active Abandoned
- 2001-12-19 EP EP01271540A patent/EP1350099B1/en not_active Expired - Lifetime
- 2001-12-19 CA CA2432452A patent/CA2432452C/en not_active Expired - Fee Related
- 2001-12-19 ES ES01271174T patent/ES2421722T3/en not_active Expired - Lifetime
- 2001-12-19 ES ES01271540T patent/ES2338521T3/en not_active Expired - Lifetime
- 2001-12-19 ES ES06076969.2T patent/ES2552909T3/en not_active Expired - Lifetime
- 2001-12-19 IL IL15639701A patent/IL156397A0/en unknown
- 2001-12-19 WO PCT/GB2001/005634 patent/WO2002049507A1/en active Application Filing
- 2001-12-19 JP JP2002551583A patent/JP3923429B2/en not_active Expired - Fee Related
- 2001-12-19 US US10/432,827 patent/US20040096959A1/en not_active Abandoned
- 2001-12-19 JP JP2002550853A patent/JP3935842B2/en not_active Expired - Lifetime
- 2001-12-19 US US10/432,276 patent/US7005857B2/en not_active Expired - Lifetime
- 2001-12-19 AT AT01271540T patent/ATE457064T1/en not_active IP Right Cessation
- 2001-12-19 CN CNB018227333A patent/CN1292703C/en not_active Expired - Fee Related
- 2001-12-19 IL IL15630201A patent/IL156302A0/en active IP Right Grant
- 2001-12-19 EP EP06076969.2A patent/EP1769735B1/en not_active Expired - Lifetime
- 2001-12-19 ES ES10182356.5T patent/ES2600627T3/en not_active Expired - Lifetime
-
2003
- 2003-06-04 IL IL156302A patent/IL156302A/en not_active IP Right Cessation
-
2004
- 2004-10-20 HK HK04108215.8A patent/HK1065591A1/en not_active IP Right Cessation
- 2004-11-24 HK HK04109280A patent/HK1066156A1/en not_active IP Right Cessation
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4873993A (en) * | 1986-07-22 | 1989-10-17 | Personal Diagnostics, Inc. | Cuvette |
WO1995010221A2 (en) * | 1993-10-09 | 1995-04-20 | Jakob Korf | Monitoring the concentration of a substance or a group of substances in a body fluid |
WO1995033504A1 (en) | 1994-06-06 | 1995-12-14 | The Regents Of The University Of California | Ic-processed microneedles |
WO1997019344A1 (en) * | 1995-11-22 | 1997-05-29 | Legacy Good Samaritan Hospital And Medical Center | Device for monitoring changes in analyte concentration |
US5801057A (en) | 1996-03-22 | 1998-09-01 | Smart; Wilson H. | Microsampling device and method of construction |
US6083196A (en) | 1997-12-11 | 2000-07-04 | Alza Corporation | Device for enhancing transdermal agent flux |
WO2000022977A1 (en) | 1998-10-19 | 2000-04-27 | Meinhard Knoll | Minimally invasive sensor system |
WO2000074766A1 (en) | 1999-06-09 | 2000-12-14 | The Procter & Gamble Company | Intracutaneous edged microneedle structure |
WO2001064105A1 (en) | 2000-03-02 | 2001-09-07 | Inverness Medical Technology, Inc. | Combined lancet and electrochemical analyte-testing apparatus |
Cited By (173)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8551308B2 (en) | 1999-10-04 | 2013-10-08 | Roche Diagnostics Operations, Inc. | Biosensor and method of making |
US8287703B2 (en) | 1999-10-04 | 2012-10-16 | Roche Diagnostics Operations, Inc. | Biosensor and method of making |
US7144495B2 (en) | 2000-12-13 | 2006-12-05 | Lifescan, Inc. | Electrochemical test strip with an integrated micro-needle and associated methods |
US9694144B2 (en) | 2001-06-12 | 2017-07-04 | Sanofi-Aventis Deutschland Gmbh | Sampling module device and method |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9802007B2 (en) | 2001-06-12 | 2017-10-31 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US8845550B2 (en) | 2001-06-12 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9937298B2 (en) | 2001-06-12 | 2018-04-10 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7288073B2 (en) | 2001-07-20 | 2007-10-30 | Roche Diagnostics Operations, Inc. | System for withdrawing small amounts of body fluid |
US8388552B2 (en) | 2001-07-20 | 2013-03-05 | Roche Diagnostics Operations, Inc. | System for withdrawing small amounts of body fluid |
US8821413B2 (en) | 2001-07-20 | 2014-09-02 | Roche Diagnostics Operations, Inc. | System for withdrawing small amounts of body fluid |
US7993284B2 (en) | 2001-07-20 | 2011-08-09 | Roche Diagnostics Operations, Inc. | System for withdrawing small amounts of body fluid |
US9560993B2 (en) | 2001-11-21 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US9603562B2 (en) | 2002-02-08 | 2017-03-28 | Intuity Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
US10772550B2 (en) | 2002-02-08 | 2020-09-15 | Intuity Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
EP1346686A3 (en) * | 2002-03-05 | 2004-06-16 | Bayer Healthcare, LLC | Fluid collection apparatus having an integrated lancet and reaction area |
US9839386B2 (en) | 2002-04-19 | 2017-12-12 | Sanofi-Aventis Deustschland Gmbh | Body fluid sampling device with capacitive sensor |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9724021B2 (en) | 2002-04-19 | 2017-08-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8905945B2 (en) | 2002-04-19 | 2014-12-09 | Dominique M. Freeman | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9089678B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9907502B2 (en) | 2002-04-19 | 2018-03-06 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9072842B2 (en) | 2002-04-19 | 2015-07-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9498160B2 (en) | 2002-04-19 | 2016-11-22 | Sanofi-Aventis Deutschland Gmbh | Method for penetrating tissue |
US9186468B2 (en) | 2002-04-19 | 2015-11-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9089294B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US8690796B2 (en) | 2002-04-19 | 2014-04-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US8845549B2 (en) | 2002-04-19 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Method for penetrating tissue |
US9339612B2 (en) | 2002-04-19 | 2016-05-17 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7343188B2 (en) | 2002-05-09 | 2008-03-11 | Lifescan, Inc. | Devices and methods for accessing and analyzing physiological fluid |
EP1980206A1 (en) | 2002-05-09 | 2008-10-15 | Lifescan, Inc. | Minimal procedure analyte test system |
EP1391716A2 (en) * | 2002-08-23 | 2004-02-25 | Lifescan, Inc. | Electrochemical test strip with an integrated micro-needle and associated methods |
EP1391716A3 (en) * | 2002-08-23 | 2005-11-16 | Lifescan, Inc. | Electrochemical test strip with an integrated micro-needle and associated methods |
AU2003286783B2 (en) * | 2002-10-30 | 2007-05-17 | Lifescan, Inc. | Improved method of lancing skin for the extraction of blood |
WO2004041088A1 (en) * | 2002-10-30 | 2004-05-21 | Lifescan, Inc. | Method of lancing skin for the extraction of blood |
US10531827B2 (en) | 2002-12-13 | 2020-01-14 | 2Breathe Technologies Ltd. | Apparatus and method for beneficial modification of biorhythmic activity |
US20060204399A1 (en) * | 2002-12-30 | 2006-09-14 | Freeman Dominique M | Method and apparatus using optical techniques to measure analyte levels |
US9034639B2 (en) | 2002-12-30 | 2015-05-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US8574895B2 (en) * | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US9095292B2 (en) | 2003-03-24 | 2015-08-04 | Intuity Medical, Inc. | Analyte concentration detection devices and methods |
US7169117B2 (en) | 2003-03-28 | 2007-01-30 | Lifescan, Inc. | Integrated lance and strip for analyte measurement |
EP1464284A1 (en) * | 2003-03-28 | 2004-10-06 | Lifescan, Inc. | Integrated lance and strip for analyte measurement |
US7473264B2 (en) | 2003-03-28 | 2009-01-06 | Lifescan, Inc. | Integrated lance and strip for analyte measurement |
EP1674037A1 (en) | 2003-03-28 | 2006-06-28 | Lifescan, Inc. | Integrated lance and strip for analyte measurement |
EP1479344A1 (en) * | 2003-05-22 | 2004-11-24 | Roche Diagnostics GmbH | Direct monitoring of interstitial fluid composition |
WO2004103186A1 (en) * | 2003-05-22 | 2004-12-02 | Roche Diagnostics Gmbh | Direct monitoring of interstitial fluid composition |
US7258673B2 (en) | 2003-06-06 | 2007-08-21 | Lifescan, Inc | Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein |
US10034628B2 (en) | 2003-06-11 | 2018-07-31 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US9144401B2 (en) | 2003-06-11 | 2015-09-29 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
EP1635700A1 (en) * | 2003-06-13 | 2006-03-22 | Pelikan Technologies Inc. | Method and apparatus for a point of care device |
WO2004112602A1 (en) | 2003-06-13 | 2004-12-29 | Pelikan Technologies, Inc. | Method and apparatus for a point of care device |
EP1635700A4 (en) * | 2003-06-13 | 2009-05-13 | Pelikan Technologies Inc | Method and apparatus for a point of care device |
US8507289B1 (en) | 2003-06-20 | 2013-08-13 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US8211379B2 (en) | 2003-06-20 | 2012-07-03 | Roche Diagnostics Operations, Inc. | Test strip with slot vent opening |
US8298828B2 (en) | 2003-06-20 | 2012-10-30 | Roche Diagnostics Operations, Inc. | System and method for determining the concentration of an analyte in a sample fluid |
US7727467B2 (en) | 2003-06-20 | 2010-06-01 | Roche Diagnostics Operations, Inc. | Reagent stripe for test strip |
US7749437B2 (en) | 2003-06-20 | 2010-07-06 | Roche Diagnostics Operations, Inc. | Method and reagent for producing narrow, homogenous reagent stripes |
US8222044B2 (en) | 2003-06-20 | 2012-07-17 | Roche Diagnostics Operations, Inc. | Test strip with flared sample receiving chamber |
US8663442B2 (en) | 2003-06-20 | 2014-03-04 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
US8586373B2 (en) | 2003-06-20 | 2013-11-19 | Roche Diagnostics Operations, Inc. | System and method for determining the concentration of an analyte in a sample fluid |
US7829023B2 (en) | 2003-06-20 | 2010-11-09 | Roche Diagnostics Operations, Inc. | Test strip with vent opening |
US8142721B2 (en) | 2003-06-20 | 2012-03-27 | Roche Diagnostics Operations, Inc. | Test strip with slot vent opening |
US8119414B2 (en) | 2003-06-20 | 2012-02-21 | Roche Diagnostics Operations, Inc. | Test strip with slot vent opening |
US7879618B2 (en) | 2003-06-20 | 2011-02-01 | Roche Diagnostics Operations, Inc. | Method and reagent for producing narrow, homogenous reagent strips |
US8071030B2 (en) | 2003-06-20 | 2011-12-06 | Roche Diagnostics Operations, Inc. | Test strip with flared sample receiving chamber |
EP1491143A1 (en) * | 2003-06-27 | 2004-12-29 | SensLab - Gesellschaft zur Entwicklung und Herstellung bioelektrochemischer Sensoren mbH | Diagnostic or analytic device for single use with integrated lancet |
US7223248B2 (en) | 2003-08-13 | 2007-05-29 | Lifescan, Inc. | Packaged medical device with a deployable dermal tissue penetration member |
JP2007504434A (en) * | 2003-08-28 | 2007-03-01 | エポカル インコーポレイティド | Lateral flow diagnostic device using instrument-controlled fluidics |
US7722817B2 (en) | 2003-08-28 | 2010-05-25 | Epocal Inc. | Lateral flow diagnostic devices with instrument controlled fluidics |
JP2005077412A (en) * | 2003-08-28 | 2005-03-24 | Lifescan Inc | Analysis device and method equipped with estimation module |
US8124026B2 (en) | 2003-08-28 | 2012-02-28 | Epocal Inc. | Lateral flow diagnostic devices with instrument controlled fluidics |
US8277636B2 (en) | 2003-09-02 | 2012-10-02 | Koji Sode | Glucose sensor and glucose level measuring apparatus |
KR101165102B1 (en) * | 2003-09-03 | 2012-07-12 | 라이프 패치 인터내셔널, 인크. | Personal diagnostic devices and related methods |
JP2007503958A (en) * | 2003-09-03 | 2007-03-01 | ライフパッチ インターナショナル,インコーポレイテッド | Personal diagnostic equipment and related methods |
US11737694B2 (en) | 2003-09-03 | 2023-08-29 | Life Patch International, Inc. | Personal diagnostic device having a plurality of tubules |
US9993189B2 (en) | 2003-09-03 | 2018-06-12 | Life Patch International | Personal diagnostic device having a fluidic circuit with a plurality of analysis chambers |
US9133024B2 (en) | 2003-09-03 | 2015-09-15 | Brigitte Chau Phan | Personal diagnostic devices including related methods and systems |
AU2004270984B2 (en) * | 2003-09-11 | 2009-05-14 | Ben-Gurion University Of The Negev Research And Development Authority | Sampling instrument |
EP1518509A1 (en) | 2003-09-19 | 2005-03-30 | Diabetes Diagnostics, Inc. | Medical device package, kit and associated methods |
US7617932B2 (en) | 2003-09-19 | 2009-11-17 | Diabetes Diagnostics, Inc. | Medical device package, kit and associated methods |
US8945910B2 (en) | 2003-09-29 | 2015-02-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
WO2005034752A1 (en) | 2003-10-06 | 2005-04-21 | Lifescan Scotland Ltd | A lancing device using a piezoelectric actuator |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
US7655119B2 (en) | 2003-10-31 | 2010-02-02 | Lifescan Scotland Limited | Meter for use in an improved method of reducing interferences in an electrochemical sensor using two different applied potentials |
US7653492B2 (en) | 2003-10-31 | 2010-01-26 | Lifescan Scotland Limited | Method of reducing the effect of direct interference current in an electrochemical test strip |
US7618522B2 (en) | 2003-10-31 | 2009-11-17 | Lifescan Scotland Limited | Method of reducing interferences in an electrochemical sensor using two different applied potentials |
US8333752B2 (en) | 2003-11-06 | 2012-12-18 | Lifescan, Inc. | Drug delivery with event notification |
US8551039B2 (en) | 2003-11-06 | 2013-10-08 | Lifescan, Inc. | Drug delivery with event notification |
US8306592B2 (en) | 2003-12-19 | 2012-11-06 | Olympus Corporation | Capsule medical device |
US9561000B2 (en) | 2003-12-31 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US7842235B2 (en) | 2004-02-14 | 2010-11-30 | Roche Diagnostics Operations, Inc. | Test element, system, and method of controlling the wetting of same |
EP1566146A1 (en) | 2004-02-19 | 2005-08-24 | Lifescan, Inc. | Devices and methods for extracting bodily fluids |
US8814808B2 (en) | 2004-03-06 | 2014-08-26 | Roche Diagnostics Operations, Inc. | Body fluid sampling device |
US9022952B2 (en) | 2004-03-06 | 2015-05-05 | Roche Diagnostics Operations, Inc. | Body fluid sampling device |
US8162854B2 (en) | 2004-03-06 | 2012-04-24 | Roche Diagnostics Operations, Inc. | Body fluid sampling device |
US8000762B2 (en) | 2004-03-06 | 2011-08-16 | Roche Diagnostics Operations, Inc. | Body fluid sampling device |
US8369918B2 (en) | 2004-03-06 | 2013-02-05 | Roche Diagnostics Operations, Inc. | Body fluid sampling device |
US7819822B2 (en) | 2004-03-06 | 2010-10-26 | Roche Diagnostics Operations, Inc. | Body fluid sampling device |
US6990849B2 (en) | 2004-03-26 | 2006-01-31 | Lifescan, Inc. | Microfluidic analytical system with position electrodes |
EP1580552A1 (en) * | 2004-03-26 | 2005-09-28 | Lifescan, Inc. | Microfluidic analytical system with position electrodes |
US7665303B2 (en) | 2004-03-31 | 2010-02-23 | Lifescan Scotland, Ltd. | Method of segregating a bolus of fluid using a pneumatic actuator in a fluid handling circuit |
US7516845B2 (en) | 2004-03-31 | 2009-04-14 | Inverness Medical Limited | Medical device package with deformable projections |
EP1582169A2 (en) | 2004-03-31 | 2005-10-05 | Inverness Medical Limited | Medical device package with deformable retaining projections |
US9261476B2 (en) | 2004-05-20 | 2016-02-16 | Sanofi Sa | Printable hydrogel for biosensors |
JP4555609B2 (en) * | 2004-05-21 | 2010-10-06 | 東亜ディーケーケー株式会社 | Gas-liquid reaction unit and analyzer |
JP2005329365A (en) * | 2004-05-21 | 2005-12-02 | Dkk Toa Corp | Gas-liquid reaction unit and analyzer |
JP4555610B2 (en) * | 2004-05-21 | 2010-10-06 | 東亜ディーケーケー株式会社 | Gas-liquid reaction unit and analyzer |
JP2005329364A (en) * | 2004-05-21 | 2005-12-02 | Dkk Toa Corp | Gas-liquid reaction unit and analyzer |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9410915B2 (en) | 2004-06-18 | 2016-08-09 | Roche Operations Ltd. | System and method for quality assurance of a biosensor test strip |
EP1612143A1 (en) | 2004-06-29 | 2006-01-04 | Lifescan Scotland Ltd | Apparatus for the packaging of medical devices including integrated lancets |
US7051495B2 (en) | 2004-06-29 | 2006-05-30 | Lifescan Scotland Limited | Method of packaging integrated biosensors |
EP1611849A1 (en) | 2004-06-29 | 2006-01-04 | Lifescan, Inc. | Method of manufacturing integrated biosensors |
EP1612142A1 (en) | 2004-06-29 | 2006-01-04 | Lifescan Scotland Ltd | Method for the packaging of medical devices, in particular integrated biosensors |
EP1611842A1 (en) | 2004-06-29 | 2006-01-04 | Lifescan, Inc. | Apparatus for the manufacture of medical devices |
EP1611839A1 (en) | 2004-06-30 | 2006-01-04 | Lifescan Scotland Ltd | Methods of monitoring the concentration of an analyte |
EP1611848A1 (en) | 2004-06-30 | 2006-01-04 | Lifescan Scotland Ltd | Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein |
EP1612430A3 (en) * | 2004-06-30 | 2007-12-05 | Lifescan Scotland Ltd | Methods for modulation of flow in a microfluidic pathway |
KR101233126B1 (en) * | 2004-06-30 | 2013-02-15 | 라이프스캔 스코트랜드 리미티드 | Fluid handling device |
EP1612430A2 (en) | 2004-06-30 | 2006-01-04 | Lifescan Scotland Ltd | Methods for modulation of flow in a microfluidic pathway |
EP1612429A3 (en) * | 2004-06-30 | 2007-09-05 | Lifescan Scotland Ltd | Microfluidic flow modulation device |
EP1611836A2 (en) | 2004-06-30 | 2006-01-04 | Lifescan Scotland Ltd | Fluid handling methods |
EP1611837A2 (en) | 2004-06-30 | 2006-01-04 | Lifescan Scotland Ltd | Fluid handling devices |
EP1612429A2 (en) | 2004-06-30 | 2006-01-04 | Lifescan Scotland Ltd | Microfluidic flow modulation device |
US8192787B2 (en) | 2004-08-16 | 2012-06-05 | Innoture Limited | Method of producing a microneedle or microimplant |
US7402616B2 (en) | 2004-09-30 | 2008-07-22 | Lifescan, Inc. | Fusible conductive ink for use in manufacturing microfluidic analytical systems |
US10226208B2 (en) | 2005-06-13 | 2019-03-12 | Intuity Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
US8969097B2 (en) | 2005-06-13 | 2015-03-03 | Intuity Medical, Inc. | Analyte detection devices and methods with hematocrit-volume correction and feedback control |
US9366636B2 (en) | 2005-06-13 | 2016-06-14 | Intuity Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
US11419532B2 (en) | 2005-06-13 | 2022-08-23 | Intuity Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
US8012103B2 (en) | 2005-09-30 | 2011-09-06 | Intuity Medical, Inc. | Catalysts for body fluid sample extraction |
US10842427B2 (en) | 2005-09-30 | 2020-11-24 | Intuity Medical, Inc. | Body fluid sampling arrangements |
EP3165165A1 (en) * | 2005-09-30 | 2017-05-10 | Intuity Medical, Inc. | Devices for faciliating fluid transport |
US10441205B2 (en) | 2005-09-30 | 2019-10-15 | Intuity Medical, Inc. | Multi-site body fluid sampling and analysis cartridge |
US10433780B2 (en) | 2005-09-30 | 2019-10-08 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
WO2007041062A2 (en) | 2005-09-30 | 2007-04-12 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
US9380974B2 (en) | 2005-09-30 | 2016-07-05 | Intuity Medical, Inc. | Multi-site body fluid sampling and analysis cartridge |
US9839384B2 (en) | 2005-09-30 | 2017-12-12 | Intuity Medical, Inc. | Body fluid sampling arrangements |
US9060723B2 (en) | 2005-09-30 | 2015-06-23 | Intuity Medical, Inc. | Body fluid sampling arrangements |
US8012104B2 (en) | 2005-09-30 | 2011-09-06 | Intuity Medical, Inc. | Catalysts for body fluid sample extraction |
US8815076B2 (en) | 2006-10-05 | 2014-08-26 | Lifescan Scotland Limited | Systems and methods for determining a substantially hematocrit independent analyte concentration |
US8460537B2 (en) | 2006-10-05 | 2013-06-11 | Lifescan Scotland Limited | Methods for determining an analyte concentration using signal processing algorithms |
US9046480B2 (en) | 2006-10-05 | 2015-06-02 | Lifescan Scotland Limited | Method for determining hematocrit corrected analyte concentrations |
US8293096B2 (en) | 2006-10-05 | 2012-10-23 | Lifescan Scotland Limited | Systems and methods for determining a substantially hematocrit independent analyte concentration |
US8388821B2 (en) | 2006-10-05 | 2013-03-05 | Lifescan Scotland Limited | Method for determining hematocrit corrected analyte concentrations |
EP2142096A4 (en) * | 2007-04-04 | 2010-12-29 | Isense Corp | Analyte sensing device having one or more sensing electrodes |
WO2008124597A1 (en) | 2007-04-04 | 2008-10-16 | Isense Corporation | Analyte sensing device having one or more sensing electrodes |
EP2142096A1 (en) * | 2007-04-04 | 2010-01-13 | Isense Corporation | Analyte sensing device having one or more sensing electrodes |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US11045125B2 (en) | 2008-05-30 | 2021-06-29 | Intuity Medical, Inc. | Body fluid sampling device-sampling site interface |
US9833183B2 (en) | 2008-05-30 | 2017-12-05 | Intuity Medical, Inc. | Body fluid sampling device—sampling site interface |
US10383556B2 (en) | 2008-06-06 | 2019-08-20 | Intuity Medical, Inc. | Medical diagnostic devices and methods |
US9636051B2 (en) | 2008-06-06 | 2017-05-02 | Intuity Medical, Inc. | Detection meter and mode of operation |
US11399744B2 (en) | 2008-06-06 | 2022-08-02 | Intuity Medical, Inc. | Detection meter and mode of operation |
US11553860B2 (en) | 2008-06-06 | 2023-01-17 | Intuity Medical, Inc. | Medical diagnostic devices and methods |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US9897610B2 (en) | 2009-11-30 | 2018-02-20 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
US8919605B2 (en) | 2009-11-30 | 2014-12-30 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
US11002743B2 (en) | 2009-11-30 | 2021-05-11 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
US11933789B2 (en) | 2009-11-30 | 2024-03-19 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US10330667B2 (en) | 2010-06-25 | 2019-06-25 | Intuity Medical, Inc. | Analyte monitoring methods and systems |
US11051734B2 (en) | 2011-08-03 | 2021-07-06 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
US11382544B2 (en) | 2011-08-03 | 2022-07-12 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
US9782114B2 (en) | 2011-08-03 | 2017-10-10 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
US11672452B2 (en) | 2011-08-03 | 2023-06-13 | Intuity Medical, Inc. | Devices and methods for body fluid sampling and analysis |
US10729386B2 (en) | 2013-06-21 | 2020-08-04 | Intuity Medical, Inc. | Analyte monitoring system with audible feedback |
US20200330016A1 (en) * | 2017-12-15 | 2020-10-22 | Koninklijke Philips N.V. | Wearable or insertable devices with microneedles that include mechanically-responsive material |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2432452C (en) | Analyte measurement | |
JP2004520103A5 (en) | ||
US6398562B1 (en) | Device and methods for the application of mechanical force to a gel/sensor assembly | |
CN103932718B (en) | The portable monitoring system of thing is analyzed in dynamic METHOD FOR CONTINUOUS DETERMINATION body fluid | |
KR100869655B1 (en) | Biological fluid constituent sampling and measurement devices | |
US20080312518A1 (en) | On-demand analyte monitor and method of use | |
US20100049021A1 (en) | Devices, systems, methods and tools for continuous analyte monitoring | |
KR20030013260A (en) | Devices for analyte concentration determination and methods of using the same | |
CN1456890A (en) | Physiological sample collector and use method thereof | |
WO2010059276A1 (en) | Devices, systems, methods and tools for continuous analyte monitoring | |
US20170188898A1 (en) | Devices and methods for enhanced skin perforation for continuous glucose monitoring | |
WO2014108087A1 (en) | Portable monitoring system for dynamically and continuously measuring analyte in body liquid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 156397 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001271174 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002550853 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2432452 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018227333 Country of ref document: CN |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001271174 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10432827 Country of ref document: US |